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Two experiments evaluated the effects of delayed, long-acting coated implants or
uncoated implants to non-implanted heifers fed for constant or varying days on feed. In
Exp. 1, heifers were implanted with either Revalor-XH on d 1, Revalor-200 on d 1,
Revalor-XR on d 1, or Revalor-200 on d 70 compared to non-implanted control heifers
when fed for an average of 198 d. In Exp. 2, heifers were implanted with Revalor-200 on
d 1 and reimplanted with Revalor-200 on d 100, Revalor-XH on d 1, or not implanted and
fed for different days on feed: 151, 165, 179, or 193. Implanting heifers increased BW,
ADG, G:F and HCW compared to non-implanted heifers with no differences between
implant strategies. As heifers were fed for longer DOF, ADG and G:F decreased.
Implanting and increasing DOF substantially increased BW and HCW but increasing
initial implant dosage did not result in a performance advantage when heifers were fed
for varying DOF.
Two experiments evaluated the effect of timing of administering a terminal
implant in heifers and steers when fed for 180 days. In Exp. 3, heifers were implanted
with Revalor-IH and reimplanted with Revalor-200 at 20, 60, 100 or 140 DOF. In Exp. 4,
steers were implanted with Revalor-IS and reimplanted with Revalor-200 on 20, 60, 80,

100 or 140 DOF. In Exp. 3, final BW, ADG, G:F, HCW and LM area responded
quadratically and were maximized between 88 and 103 on terminal (DOT) implant. In
Exp. 4, carcass-adjusted final BW, ADG, G:F and HCW responded quadratically and was
optimized between 87 and 104 DOT. Therefore, the optimal duration for a terminal
implant appears to be between 80 and 120 DOT, with an average of 96 DOT for both
heifers and steers.
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Introduction
Profitability in the cattle feeding industry is driven by weight gain and efficiency
in the feedlot. The feeding industry is constantly evolving and adapting innovative
technologies to achieve more profit efficiently.
Steroidal combination implants have been extensively used and studied for over
50 years. Implants have consistently been shown to increase gain and hot carcass weight
by increasing frame size and delaying fattening (Reinhardt, 2007; Smith et al., 2018).
However, due to this effect, cattle must be fed for longer days on feed (DOF) to achieve
similar fatness to non-implanted cattle. Traditionally, the payout of most uncoated
implants is approximately 60 to 120 days (Mader, 1998). More recently, cattle producers
have been feeding cattle for longer DOF which causes logistical issues for reimplanting.
The FDA has approved the use of coated implants, which delays the release of the partial
or entire dose of the steroidal hormones until approximately 70 to 80 d after implanting.
These long-lasting implants may remove the need to reimplant, potentially reducing the
cost and logistical issues sometimes associated with reimplanting.
The ideal time to administer the terminal implant following an initial implant has
recently been of interest. Duckett and Pratt (2014) demonstrated that both steers and
heifers given an initial implant and reimplanted with a combination terminal implant had
a 20% increase in ADG and 13.5% increase in G:F compared to non-implanted cattle.
However, the data describing the optimal time to administer a terminal implant are
limited, and most recommendations come from anecdotal evidence or consultant’s
individual experiences.
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Therefore, the objectives of this study were: to evaluate the effects of coated longacting, delayed release implants in heifers fed for constant DOF or the effect of
traditional, aggressive implant strategies compared to long lasting implants when heifers
are fed varying DOF (Exp. 1 and 2) and evaluate and define the optimal time to reimplant
heifers and steers following a mild initial implant (Exp. 3 and 4).
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CHAPTER I. Review of Literature
Overview of Implants

Growth Promoting Anabolic Steroids
Anabolic steroids are a group of natural or synthetic estrogens (female hormone)
or androgens (male hormone) approved for use in beef cattle for growth promoting
purposes (Meyer, 2001). Since the 1950s, many steroid hormone drugs have been
approved for use in beef and sheep production, including estrogen, progesterone,
testosterone, and synthetic versions of all compounds (FDA, 2017). These compounds
have been shown to improve growth rate, feed efficiency and protein deposition in
experimental or commercial use (Montgomery et al., 2001). According to the USDA
National Animal Health Monitoring System survey of feedlots in 12 major cattle feeding
states with over 1,000-head capacity, 97% of all cattle entering the feedlot at greater than
318 kg were implanted at least one time. Of that 97%, 30% were implanted twice.
Furthermore, 60% of the cattle implanted once received an androgenic compound and of
the cattle implanted twice, 78% received an androgenic compound (Duckett and Andrae,
2001; Johnson and Beckett, 2014).
Implants are approved for most segments of beef production, including suckling,
grazing, and finishing steers and heifers (Duckett and Andrae, 2001) and if used properly,
can have a substantial return on investment (Hutcheson, 1993). While the return on
investment varies, it is estimated to be greater than $5 per $1 spent (ZoBell, et al., 2000).
There are several diverse types of single and combination ingredients used in
implants, including Estradiol-17β (E17), zeranol, trenbolone acetate (TBA), and

12

progesterone. However, most implants are comprised of estrogens, androgens, progestins,
which are all naturally-occurring in all animals, regardless of gender (Johnson and
Beckett, 2014). These compounds, or the combination of two, account for all
commercially available implants (Botts, 1997). It is estimated that nearly two-thirds of all
marketed implants in the United States are a combination of TBA/E17 (Johnson and
Beckett, 2014), and therefore will be the focus for this review. Implants are approved to
be administered subcutaneously in the middle third of the back of the ear, which allows
for a slow, consistent steroid release into the blood stream to be administered to body
tissues, without the implant site (ear tissue) entering the human food supply (Johnson and
Beckett, 2014).
Mode of Action
Steroidal hormones elicit a response by working through the endocrine and
paracrine systems and their hormones to regulate growth and protein metabolism (Meyer,
2001). In general, steroid implants act primarily by binding to cytosolic receptors, which
then act on the nucleus to promote gene expression and translation of growth-promoting
hormones such as IGF-1 and growth hormone (Bryant et al., 2010). It is widely accepted
that cattle implanted with a combination of TBA and E17 experience a synergistic effect
and show an increase in performance compared to cattle implanted with TBA or E17
alone (Pampusch et al., 2008; Reinhardt, 2007). However, it is important to evaluate
these compounds individually first to fully understand how they work effectively
together.
Estradiol-17β has a greater anabolic effect compared to androgens in cattle and
sheep and growth related to E17 seems to be dose-dependent (Meyer, 2001). Meyer
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(2001) proposed possible indirect and direct effects of E17. The author discussed that
E17 stimulates and increases estrogen receptors on the skeletal muscle cells, which in
turn, increases stimulation of muscle mRNA to increase protein anabolism and mineral
retention. Estradiol-17β acts indirectly on the hypothalamus to secrete more growthhormone releasing hormone or directly by stimulating the pituitary gland to secrete more
growth hormone, and therefore increase growth hormone receptors in the liver, and
release more insulin-like growth factor 1 (IGF1) into the blood stream (Trenkle, 1997;
Meyer, 2001). Increased levels of IGF-1 and IGF-1 mRNA have a positive effect on
increasing protein accretion of existing muscle fibers and promoting hypertrophy of
skeletal muscle (Kamanga-Sollo et al., 2008; Johnson and Beckett, 2014). However, to
sustain long-lasting hypertrophy since the number of muscle fibers is essentially fixed at
birth, there needs to be proliferation of new cells through stimulation of inactive satellite
cells by IGF-1 (Johnson and Chung, 2007; Kamanga-Sollo et al., 2008).
Trenbolone belongs to a group of the most efficient anabolic steroids, likely due
to its multiple hormonal activity (Meyer, 2001). While the exact mechanism of
trenbolone on growth and efficiency of cattle is not completely understood, it is believed
that trenbolone acts like other androgens, and exhibits strong binding to the androgen
receptor, progestin receptor, and glucocorticoid receptor (Meyer, 2001). Meyer (2001)
also proposed that trenbolone suppresses tyrosine amino transferase and consequently
prevents amino acid catabolism when compared to testosterone or other androgens.
Furthermore, the author concludes that trenbolone acts as an anti-glucocorticoid by
binding to the glucocorticoid receptor and further prevents catabolic activity. While it is
thought that TBA has very limited stimulatory effect on muscle IGF-1, it is believed that
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TBA is the most efficient at acting directly on the muscle cells through several pathways
to promote proliferation of bovine satellite cell cultures (Pampusch et al., 2008; Johnson
and Beckett, 2014). However, as previously mentioned, the combination of E17 and TBA
have a greater response than when E17 or TBA are used independently (Hayden et al.,
1992; Dayton and White, 2008; Pampusch et al., 2008; Johnson and Beckett, 2014). It is
believed that E17 stimulates muscle protein deposition and TBA works to enhance this
effect, and because of the increase of muscle protein deposition, it is the increase in
muscle synthesis and not the decrease of muscle protein degradation that causes the
responses observed from the use of combination implants. However, the exact
mechanism of how these two hormones work on other growth promoting hormones and
their receptors and tissues is not fully understood and warrant further research (Hayden et
al., 1992; Pampusch, et al., 2008).
Using a combination implant of TBA/E17 promotes an increase in muscle
hypertrophy and protein synthesis in the first 40 days after implantation compared to nonimplanted cattle (Johnson and Chung, 2007; Chung et al., 2012). To support increased
muscle hypertrophy and protein synthesis, quiescent cells, which contribute to the growth
plateau observed in control cattle, must be activated, increase DNA, and then be acted
upon by growth factors, such as IGF-1, to further promote cell growth and proliferation
(Johnson and Chung, 2007; Dayton and White, 2008; Chung et al., 2012). Combination
implants lead to an increase in IGF-1 and IGF-1 mRNA in longissimus muscle, which
can support an increase in muscle hypertrophy (Johnson and Chung, 2007). Additionally,
TBA/E17 has been shown to increase the rate in which cell proliferation occurs in vitro
(Dayton and White, 2008).
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Release Rate and Factors that Influence
There are two distinct styles of manufacturing of implants: compressed pellets
and silastic rubber. Generally, silastic rubber is used with estradiol implants, whereas
compressed pellets can be used with TBA, E17, or combination implants. Because
compressed pellets are the most common implant type, they will be the focus of this
review. These types of pellets are generally a mix between the active ingredient and a
carrier, such as lactose, cholesterol, or a large polymer of polyethylene glycol ( Preston,
1999; Cady et al., 2002). The use of lactose or cholesterol allows the compressed pellets
to dissolve completely overtime at rates dependent on several factors, such as type of
carrier used and pressure utilized to form the compressed pellet (Istasse et al., 1988;
Jennings, 2012). Targeted release rate to the animal is between 0.75 mg/day/animal to 1.2
mg/day/animal, which is desired to attain the performance response for the period that the
animal is in the feedlot (Cady, 2002).
Compressed implants were first used when diethylstilbestrol (DES) was approved
for implanting instead of oral dose in 1955 (Raun and Preston, 2002). As previously
mentioned, compressed implants can be made with a variety of carriers, with lactose and
cholesterol being the most common. Lactose makes hard pellets that are well absorbed,
and is generally used in short-term implants, as lactose degrades over a 60 to 80-day
period. Cholesterol, on the other hand, dissolves and releases active ingredients at a much
slower rate, making it ideal for long-term implants (Bartle et al., 1992). Additionally,
compressed pellets can include an antibiotic pellet, which prevents infection at implant
site (Stevens et al., 1999). While cholesterol is generally utilized in long-acting implants,
Preston (1999) found that a response was sustained for 84 but not 126 days. Because of
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this, some implants are encapsulated in a polymer or osmotic membrane to modulate the
release rate (Preston, 1999). The pellets are generally 3 mm to 6 mm in length, with 4 to
5 mm being preferred. The pellet diameter varies from 2 mm to 4 mm, with a preferred
diameter of 2.5 to 3.5 mm. These pellets may also have a beveled edge (Cady, 2002).
The pressure used to form compressed implants is vital to the rate of release of the
active ingredient and ultimately, the payout of the implant; however, most levels of
pressure are confidential and not reported in the literature (Preston, 1999). The pressure is
measured in kiloponds (kp) and Revalor implants are compressed at 7.14 kp, and while
the exact value of force utilized to compress Synovex and Component is unknown, it is
presumably similar (Cady, 2002; Jennings, 2012). In general, the more compressed a
pellet is, the slower degradation rate and the slower release of the active ingredient.
Payout of Hormones after Implanting
The first most extensive look at hormonal payout of implants was observed with
implanting at various times with DES. Implants from different lots and manufacturers
were evaluated and it was found that the implants had different half-lives and percentages
remaining after 60 days, regardless of the manufacturer claim, all exhibiting first-order
release patterns (Preston, 1999). Similar release patterns were observed with E17 +
progesterone implants. These results and the first-order kinetics demonstrate that there is
a greater release of implant hormone during the first 60 days post implantation, with
measurable implant hormone being observed up to 120 days post-implantation (Preston,
1999).
While the concentration of hormones, namely TBA and E17, in blood, plasma, and
serum can provide useful information, it is noted there are limitations in their meaning due
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to considerable variation (Preston, 1999). Release of active ingredients in hormones are
generally biphasic, which results in an initial peak in concentration of circulating hormones
1 to 3 d after implanting, followed by a decline in concentration following first order
kinetics (Brandt, 1997; Preston, 1999). A threshold concentration is also considered where
there is no further animal response expected. The threshold concentration for E17 is
thought to be between 3 and 5 pg/ml, while the threshold level of TBA has been difficult
to define and is still unclear because there are still elevated levels remaining after 120 days
(Preston, 1999). When heifers were implanted with TBA alone or in a combination implant,
peak serum TBA levels were observed 1 day after implantation, decreased over time, and
showed a minor peak around day 56 and further decreased through day 140. However, in
the same study, E17 levels were elevated 1 day after implanting, but did not peak until 56
days after implanting. Comparable results were shown in steers (Preston, 1999).
Serum Urea-Nitrogen
Steroidal implants work as a repartitioning agent and work to increase the amount
of protein deposition and retention in the animal compared to fat (Bryant et al., 2010).
The increase in protein retention, and ultimately muscularity, can be observed in a
decrease of serum urea-nitrogen. The lower serum urea nitrogen levels indicate
alterations in nitrogen metabolism and protein turnover in implanted heifers. These
changes can also be attributed to an increased requirement for amino acids (Galbraith,
1980). Heitzman and Chan (1974) found that heifers implanted with 300 mg of TBA
showed decreased plasma urea-nitrogen 14 days post-implantation and remained lower
than non-implanted heifers until 49 days post-implantation. In similar studies, plasma
urea nitrogen was decreased, but total plasma protein was not affected when cattle were
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fed a 12% CP diet (Jennings, 2012). Further, Parr and others (2014) found that when
steers where implanted with either Revalor-S or Revalor-XS, serum urea-N
concentrations increased over time, but implanted cattle had lower levels of serum urea-N
compared to non-implanted steers.
Non-Esterified Free Fatty Acids
In general, implanting does not alter NEFA concentrations in finishing cattle
(Galbraith, 1980; Parr, et al., 2011). Enright and others (1990) evaluated the effect of
subcutaneous growth promoting injections (growth hormone and/or estradiol) on 63
Friesian steers and found that there was no effect on NEFA levels in cattle that received
any growth hormone or estradiol treatment. Similarly, when Parr et al. (2014) evaluated
the effects of no implant, Revalor-S or Revalor-XS on blood metabolites of steers
(n=168), they found that NEFA levels were not affected by implant treatment, but
increased over time, independent of implant treatment.
Live Animal Performance Response to Implants
Live animal performance in response to implant treatments has been shown to be
altered significantly. Duckett et al. (1997) summarized 77 research trials that utilized
single or multiple implants across both steers and heifers and evaluated the effect on live
performance. The authors found that both steers and heifers implanted with a
combination of TBA/E17 performed significantly better than animals that received either
an estrogen or androgen implant alone. Furthermore, implanting with a combination
implant increased ADG by 8 to 20%, DMI by 7% and improved feed efficiency by 5 to
10% depending on heifers or steers. Animals that were given an estrogen only implant
showed a 9-14% improvement in gain, 4% increase in DMI, and a 4-5% improvement in
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efficiency. Steers that received an androgen only implant showed a 16% increase in gain,
but there were no other performance responses observed.
Bartle and others (1992) evaluated the effect of TBA/E17 combination implants
and the optimum combination for steer performance. Combination implant treatments
included a 5:1 ratio of TBA/E17 and consisted of 20 mg TBA/4 mg E17, 80 mg TBA/16
mg E17, or 140 mg TBA/28 mg E17. Additionally, there was a non-implanted control
treatment, and steers that received either 140 mg TBA alone or 30 mg of E17 alone. The
authors found that there was a linear increase in ADG among the combination implants
and ADG was increased 18% over the control. Feed efficiency also improved linearly
with higher dose implants. Steers that were implanted with only E17 showed a 7%
increase in ADG and a tendency to improve feed efficiency. The authors recognized that
these values were slightly lower than other values previously reported but contributed
that to the longer duration of this feeding study (168 days) and the potency of E17
implants in longer day feeding trials. Trenbolone acetate implants alone had no effect on
performance characteristics over the control. Therefore, the author concluded that a
combination implant of 140 mg TBA/28 mg E17 resulted in the greatest performance
advantage compared to non-implanted or single E17 implanted cattle.
Guiroy and others (2002) summarized 13 implant trials that utilized 15 different
implant strategies, including a combination of non-implanted control, single implants,
and combinations of implants in both heifers and steers. The authors concluded that there
was an improvement in ADG and feed efficiency in both steers and heifers treated with
an implant strategy compared to non-implanted cattle. Furthermore, this summary further
confirmed previous work that anabolic implants increase the mature body size of steers.
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Bryant et al. (2010) compared 2 different implant strategies in both steers and heifers
compared to non-implanted controls. In steers, steers implanted with Revalor-IS and
reimplanted with Revalor-S had 10% greater final BW, 19% improvement in ADG, 12%
increase in G:F and 9% greater DMI compared to non-implanted steers. Heifers that
received Revalor-200 at trial initiation and fed for 120 d had an 4.4% increase in final
BW and 14% greater ADG compared to non-implanted heifers.
Duckett and Pratt (2014) analyzed the implant response of over 30 implant trials
updated since 1997 and found that implanting with estrogenic implants or combination
implants resulted in a 16 to 20% increase in ADG and a 9 to 14% improvement in feed
efficiency in steers compared to a nonimplanted control. Furthermore, Duckett and Pratt
evaluated the economic impact of using anabolic implants and the added performance.
The authors found that using modern prices, a combination implant would increase
returns by $163/head and if two combination implants were used, there would be an
estimated return of $218.58/head over non-implanted cattle. Therefore, the use of
anabolic implants for growth and performance purposes has become a regular practice
among feed yards to improve performance and cost of gains.
In general, anabolic implants, and more specifically, combination implants, have
been shown to improve ADG and feed efficiency when compared to non-implanted cattle
in both steers and heifers. With the increased ADG and efficiency, profitability from
implanted cattle has increased. Furthermore, implanted cattle have increased mature body
size, which potentially translates into more saleable weight, further increasing
profitability.
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Carcass Response to Implants
Duckett and Pratt (2014) summarized the effect of anabolic implants on carcass
characteristics of steers utilizing the same study as previously outlined. The authors
reported that a single estrogenic implant increased HCW by 3% over non-implanted
steers, but a single combination implant or reimplanting later in the finishing phase
resulted in a 6 to 7.5% increase in HCW over a negative control. Bryant et al. (2010)
found that steers implanted twice in the finishing phase (Revalor-IS followed by ReavlorS) had 11% greater HCW when compared to non-implanted steers. When steers were
implanted once during the finishing phase, LM area was increased by 5.8% and if
implanted twice, LM area increased 9% over non-implanted cattle. Furthermore, there
were no reported changes in fat thickness related to implant strategies, thus the increase
in LM area was directly related to the increase of HCW, so only a minor change in yield
grade was attributed to implanting (Duckett and Pratt, 2014).
Duckett and Pratt (2014) also reported that skeletal maturity increased with the
use of anabolic implants. When estrogenic implants were used, skeletal maturity was
advanced by 20 to 24% in steers. A linear increase in maturity with the number of
combination implants used in the finishing phase was also reported. However, if an
implant was given later in the finishing phase (for example, around day 60), there was no
difference in maturity score compared to non-implanted steers, but cattle implanted on
day 0 showed increased maturity scores of 11 to 16 points.
Duckett and Pratt (2014) observed a decrease in marbling scores when either
estrogenic or combination implants were utilized. When a single estrogenic implant was
used, marbling score was decreased by 3.75%, whereas with the use of a combination or
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multiple implant strategy, marbling score was reduced by 7.5 to 11.5% compared to nonimplanted cattle. Furthermore, the authors correlated the decrease in marbling score to the
increase in LM area observed with implanted cattle and found that there is a negative
relationship between the two variables. This means that as LM area increases due to
implant strategy, marbling score is reduced because of a dilution effect when cattle are
fed to similar DOF. Johnson et al. (2013) found that when cattle were fed on a time
constant-basis, implanted cattle had a 7% reduction in fat cover, implying that although
cattle gain faster than non-implanted cattle, they do not accumulate fat at a proportional
rate for the increase in growth observed with implanting. However, many research trials
comparing implant strategies have shown minimal differences in fat thickness due to
implanting (Duckett and Pratt, 2014).
Johnson et al. (1996) utilized 64 crossbred steers in a serial slaughter experiment
to observe the effects of a combination implant on live performance, carcass
characteristics, and fat deposition compared to non-implanted control cattle. Cattle were
implanted with Revalor-S (Merck Animal Health) or given no implant and were
harvested on one of 4 days consisting of days 0, 40, 115 or 143. The dates were chosen to
provide an initial carcass composition (d 0), day of maximum response to the implant (d
40), the manufacturer’s recommended date of harvest (d 115) and when circulating
hormones were projected to return to baseline levels (d 143). Overall, there were no
reported differences in HCW (353 kg vs 332 kg, respectively) or fat thickness (0.84 cm
vs 0.77 cm, respectively) between implanted and control cattle, although these numbers
were numerically increased. Between d 40 and 115, implanted cattle had greater LM area
compared to non-implanted cattle, but this advantage was not maintained at 143 days.

23

Furthermore, there were no significant effects on marbling score between d 40 and 115,
but implanted cattle had a lower numerical marbling score compared to control cattle at
143 days. Because of no observed effect on HCW, LM area, or fat deposition, there were
no differences in calculated yield grade among treatments. The lack of differences could
be due to the small number of cattle utilized or because of loss of potency of implants
later in the feeding phase (Johnson, 2013).
In a review by Montgomery et al. (2001), heifers that received an androgen
implant or a combination implant during the finishing phase had heavier HCW and an
increase in LM area compared to heifers that received only an estrogen-based implant or
no implant. Reimplanting heifers also resulted in heavier HCW and further increase in
LM area compared to non-implanted heifers. Additionally, Duckett et al. (1997) found
that the use of a single implant in heifers doesn’t seem to improve yield grade, however,
reimplanting (regardless of the implant combination) seems to improve yield grade, likely
due to a decrease in fat thickness in relation to HCW. While there is still a performance
increase from the use of implants in heifers, the magnitude in which heifers respond is
lower compared to steers.
Platter et al. (2003) found that in eleven implant strategies, including lifelong
implanting, steers that received two or fewer implants produced carcasses with greater
USDA marbling scores than cattle that received four or five implants in their lifetime and
non-implanted negative controls had the greatest marbling score compared to all implant
strategies. However, marbling score was not affected by implant strategies implemented
prior to the finishing phase. Samber et al. (1996) reported that steers that were implanted
three times in their lifetime had lower USDA marbling scores and carcasses grading
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choice or prime compared to non-implanted cattle or cattle that were delay implanted by
30 d and only given two lifetime implants. All studies discussed thus far have been
conducted on an equal DOF basis. Nichols et al. (2002) reported that when cattle are
finished to the same physiological endpoint, the percentage of protein, adipose, and bone
is similar with implanted or non-implanted cattle, yet implanted cattle maintain an
advantage in BW. This is due to implants causing an increase in the growth curve, which
modifies the use of protein vs fat deposition and modification of nutrient supply. This is
an important management strategy for feed yards to maintain performance advantages
without sacrificing carcass merit.
Implant Strategies and Ideal Reimplantation
As previously discussed, it is important for feed yards to consider and predict
carcass composition, especially with the use of implants. The length of anabolic activity,
which is commonly referred to as payout, is important to consider when designing an
implant program and these programs should be designed to achieve predetermined
performance and carcass goals (Brandt, 1997). Vasconcelos and Galyean (2007) surveyed
29 consulting nutritionists representing all cattle feeding areas of the United States and
respondents were responsible for approximately 69% of cattle on feed and provided their
recommended days on terminal implant. Of the 29 consultants surveyed, 21 consultants
recommended that the maximum days be 110 or 120 d or less. This is important to note
because as cattle are being fed longer days on feed, the need for reimplanting and
management increases in importance.
As previously discussed, active hormone components are generally delivered by
dissolution of the carrier in the implant or by dissociation of the hormone from a rubber
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carrier vehicle. The rate of release of the hormone from either method is the primary
determinant of payout period, which is defined as the length of time that an implant can
promote growth (Reinhardt, 2007). However, regardless of the payout period, an animal
requires a threshold level of exogenous hormone for a growth response to be observed.
With implanting, the highest level of delivered hormones are observed in the first 30 days
after implanting, and as delivery slows, the hormone levels fall below the threshold level
and growth enhancement seizes (Reinhardt, 2007). However, by reimplanting, feedyards
can manage the minimum threshold and restart the release pattern, allowing the growth
promoting benefits to continue with cattle fed longer DOF (Reinhardt, 2007).
Guiroy et al. (2002) studied the effect of particular implant strategies on their
ability to change final BW when animals are adjusted to same final body composition
leading to the ability for feeders to be able to choose the implant strategy that is the most
appropriate for different classes of animal and in turn, maximize profitability and meat
quality. The authors concluded that anabolic implants increase mature body size of cattle
and that implanted steers should be harvested at 39.5 kg heavier final BW and implanted
heifers at 16.8 kg heavier final BW compared to non-implanted controls to achieve
similar marbling scores. The decrease in physiological age is what causes the decrease in
marbling score when animals are fed to similar DOF because the implanted animals are at
a leaner stage of growth compared to non-implanted cattle (Reinhardt, 2007). Therefore,
animals who receive a more aggressive implant or multiple implants will require more
DOF to reach the same empty body fat percentage and equal carcass composition (Guiroy
et al., 2002).
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Mader (1997) determined that implant strategies should match implant dosage or
potency to the animal’s age, weight, and production goals to maintain blood hormone
levels in an optimum response range. Implant strategies can be tailored to fit the
individual feeder’s animal type and marketing opportunities by altering the dose of
hormone administered or the frequency of implanting. This could be of particular
importance when feeding large-framed continental breeds, which would likely require
less hormone to achieve desired carcass growth, whereas a British-influenced breed may
tolerate more aggressive implant strategies to encourage lean muscle deposition, without
sacrificing their inherent ability to deposit intramuscular fat (Johnson et al., 2013).
Ultimately, to gain optimum growth benefits of the implant, it is necessary to leave the
implant in the animal throughout the entire payout period, which is generally 50 to 200
days, depending on the implant (Johnson et al., 2013).
Other implant strategies have evaluated the effect of various initial implant doses
followed by a common terminal implant on growth performance and carcass
characteristics. Hilscher et al. (2016) evaluated three different initial implant strategies in
heifers that included: 80 mg TBA + 8 mg E2 (Revalor-IH, Merck Animal Health), 140
mg TBA + 14 mg E2 (Revalor-H, Merck Animal Health), and 200 mg TBA + 20 mg E2
(Revalor-200, Merck Animal Health), followed by 200 mg TBA + 20 mg E2 (Revalor200) 89 d later. The authors found no differences in final BW, DMI, ADG, G:F, or HCW
regardless of initial implant strategy. The author reported a tendency for a lower
calculated YG for more aggressive initial implants and a decrease in marbling score as
initial implant dose was increased. Oney et al. (2018) observed similar results in steers
when initial implant strategies were compared. There were no differences reported in
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feedlot performance or carcass performance. However, when the author analyzed interim
performance, the cattle that were more aggressively implant initially gained faster and
more efficiently early in the feeding period but lost the advantage as the feeding period
progressed. These data from Hilscher et al. (2016) and Oney et al. (2018) suggest that
aggressive initial implants have minimal impact on growth or carcass performance,
however, mild initial implants may be less detrimental on quality grade when cattle are
fed for the same number of days.
Steroidal implants are an effective non-nutritional management tool that feeders
and producers can utilize to increase the performance and economic efficiency of beef
cattle (Nichols et al., 2002). However, because of alterations in physiology of beef cattle
when implants are used, it’s important to feed cattle longer DOF or to a similar
compositional end point to avoid negative effects on carcass merit and marbling scores
(Johnson et al., 2013).
Predicting Carcass Composition
Serial Harvest
Serial harvest experiments have been vital in determining and understanding
carcass composition of beef cattle. The use of serial harvest has allowed researchers to
understand how cattle grow and accrue protein and fat as the animal matures from birth of
harvest. This information can then be used to predict the most effective nutritional and
marketing strategies for certain classes of cattle. Haecker (1915) recorded one of the first
serial harvest experiments that followed animals from approximately 1 week to 25 mo of
age, harvesting a representative animal to analyze for body composition. The author
utilized 260 steers and the representative animal was harvested at 45 kg and every 45 kg
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period thereafter. The harvested animal was analyzed for chemical composition. The data
show that there are minor variations and remarkable uniformity in the composition of steers
in the designated growth periods with very limited variation in red meat of animals of the
same breed and age. The most notable change in carcass composition occurs in fat
deposition. There is a higher affinity for accruing protein from 45 kg to 318 kg, but after
318 kg, animals begin depositing more fat rather than protein. However, this experiment
was done using British breeds, which tend to finish and mature at a more rapid rate when
compared to Continental breeds. Koch et al. (1976) studied the growth period of 14
different breed combinations that included both British and Continental breeds. The steers
that had Continental influence took more DOF to reach the same fatness as cattle of British
influence, however, at the same end point, the Continental steers had more red meat and
ultimately greater retail product. Steen and Kilpatrick (1995) supported these findings and
they concluded that animals with Limousin and Belgian Blue influence had greater lean
content in their carcasses with larger eye-muscles and a greater yield of saleable red meat,
leading to a more profitable carcass. This was further solidified using the Germplasm
Evaluation Program at the U.S. Meat Animal Research Center. Wheeler et al. (2005)
concluded at constant BF thickness, carcass from British-influenced steers were lighter
than Continental-influenced, and British influenced cattle were earlier maturing, requiring
less DOF to reach a consistent 25% fat trim endpoint. Berg and Butterfield (1968)
harvested four Hereford calves at birth and then every 6 months following until they were
24 months of age and were able to identify that animals increase bone mass early in
development, muscle intermediate, and fat late in development, or between 12 and 18 mo
of age. Serial harvest studies like the ones previous outlined are vital to the development
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of nutritional requirements for energy of maintenance and gain in beef cattle, which are
useful to determining the change in carcass composition over the feeding period.
Bruns et al (2004) evaluated the changes in carcass composition over the course of
an entire feeding period, rather than just focusing on animal performance at one-time
period. Serial harvest groups were targeted so that their HCW would be approximately 204,
250, 295, 340, and 386 kg. As DOF increased, live BW, HCW, dressing percent, LM area,
fat thickness, yield grade, and marbling score all increased linearly. The authors also
reported that as DOF increased, ADG decreased linearly. In a review by Streeter et al.
(2012), ADG was decreased and feed efficiency was decreased in steers fed for additional
days, but heifers decreased ADG at an increasing rate and increased feed efficiency when
DOF were increased. However, Zinn et al (1970) found that ADG increased with increasing
time on feed, but there were no significant differences in ADG after 120 DOF.
Vasconcelos et al. (2008) performed a feedlot trial utilizing 560 steers to evaluate
the effect of varying days on feed on performance and carcass characteristics. Treatments
included steers fed for 137 d to imitate under-finished cattle, 157 and 177 days to reach
appropriate market condition, and 198 days to imitate over-finished cattle. Cattle were
stratified by predicted DOF required to reach Choice grade and treatments were then
assigned randomly within strata. Consistent with data previously discussed, final BW
increased as DOF increased. Average daily gain and feed efficiency responded
quadratically, which agrees with data previously reported from Van Koevering et al (2005).
Relative to carcass characteristics, there was a linear increase in HCW, dressing percent,
and 12th rib fat observed as DOF increased. Further, yield grade, marbling score, LM area,
and kidney-pelvic-heart fat responded quadratically to increased DOF.
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Streeter et al. (2012) pooled three large pen studies to evaluate the effect of days
on feed (146, 167, or 188 d) on performance and carcass parameters and economic
returns based on marketing strategy when feeding heifers. Much like the previous data
presented, the author found a quadratic increase in live final BW (final BW= 0.0081*day2 +2.8061*day +1114.3) and a linear increase in HCW (HCW= 1.8554*day +
708.7), dressing percent, and percent grading choice or better, but a 7% decrease in ADG
and 8% decrease in feed efficiency.
While serial harvest experiments are usually difficult to appropriately conduct,
they have been proven to be vital to understanding changes in growth patterns and in turn
help with more accurate feeding and marketing programs.
Value of Additional Days on Feed
Utilizing data from serial harvest trials and carcass composition models, feedlot
managers can make more informed marketing decisions that are the best fit in individual
operations. This information can help feed yard managers know when to market cattle for
maximum profitability. Producers use various methods of pricing cattle at harvest.
Marketing strategies for selling fed cattle include live BW basis, HCW basis, or carcass
value grid basis. Depending on the marketing strategy decided upon by the feed yard
manager, some have reduced the number of days on feed striving for premiums for yielddriven grids or have kept cattle on feed for additional days on feed to achieve premiums
for higher grading cattle (Feuz, 2002). Hicks et al. (1987) found that cattle that were fed
for longer days on feed had heavier HCW and in turn, returned more profit because of
extra pounds sold. However, the author cautions that an increase in time led to a decrease
in live performance, and therefore, if marketed in a different scenario, could be less
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economically favorable due to increased feed costs and potential for overweight
carcasses.
Feuz (2002) conducted a simulation analysis to analyze the effects of altering
days on feed to achieve different carcass goals relative to different pricing structures. In
general, the author found that it was profitable to increase DOF due to the improvement
in quality grade and overall increase in pounds sold, which offsets the discounts for
undesirable yield grades and increased feed costs. The opposite was found in cattle that
were fed for two fewer weeks. Due to the loss in HCW, as well as no quality grade
advantage, there was a negative return in all scenarios that were simulated. The author
concluded that HCW is the driving factor in profitability and cattle should be fed longer
to achieve more revenue from more marketed pounds. Wilken et al. (2015) further
expanded on these ideas. Utilizing regression analysis, the author found that dressing
percentage increased linearly through the feeding period and could be utilized to predict
carcass weight from shrunk body weight at any point during the feeding period.
Additionally, the analysis found that BW and HCW increased linearly. However, while
live BW gain decreased during the feeding period, carcass weight gain remained
constant. Further utilizing regression analysis, the carcass weight gain expressed as a
percentage of BW gain, it is concluded that weight gain is transferred to the carcass
linearly and approached 100% as it approached the end of the feeding period. The author
concluded that producers should feed cattle fewer days if selling on a live basis to
overcome losses in live gain and efficiency but should feed cattle longer if selling on a
carcass basis to maximize revenue potential from additional HCW. Wilken et al. (2015)
further concluded that carcass feed efficiency decreases linearly on a live basis and
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quadratically on a HCW basis, which may alter the most profitable time for producers to
market their cattle on a BW or HCW basis. When modeled at $3.50/bu corn price, the
BW cost of gain ($/kg) increased quadratically (y= 0.578 + 0.0011x + 0.000008 x2) from
approximately $1.00/kg to $1.50/kg of gain when cattle were fed for 20% longer DOF.
The HCW cost of gain responded quadratically (y = 0.93 – 0.002x+ 0.00003 x2),
suggesting that there is a slight decrease in COG when cattle are marketed early and
increases as cattle are fed longer DOF. This could be of great importance when feed costs
are high and margins low, which would promote marketing cattle on a BW basis to
minimize losses or continuing to feed for 25% longer if marketed on HCW basis, as the
additional weight from added days minimizes costs for additional DOF.
Body Measurements
Advancements in understanding how carcass composition changes over time
through serial harvest studies has been instrumental in understanding appropriate times to
market fed cattle. Furthermore, body measurements can be useful in improving our
knowledge of carcass composition and providing more readily available tools to predict
terminal endpoints. Body measurements and the factors that affect the values, including
breed type, weight, condition, frame and sex have been studied extensively for over 70
years and in a review by Bruns and Pritchard (2003), their influence on body
measurements, either alone or in combination, are described in detail.
Although weight has been the primary method for how producers gauge
performance, there have been many research results that have confirmed that weight is
related to frame, backfat and muscling of the cattle (Bruns and Pritchard, 2003). Dolezal
et al. (1993) found that increased age of feeder cattle and decreased frame size was
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associated with fewer DOF. When muscle thickness was evaluated, No. 3 steers, or steers
with less muscling, required more days on feed with no differences between No. 1 or No.
2 steers. However, these effects were not consistent among age or frame size subclasses
and cannot be applied to all groups of cattle. Tatum (1986) conducted an objective
analysis on the effects of frame size and muscularity to describe morphological
differences in yearling cattle. It was found that there was a strong correlation (r = 0.96)
between frame size and mature body weight at any age. Additionally, the author
concluded that 95% of variation among subclasses of cattle can be described by two
criteria: differences in frame size and dimensional variation corresponding to differences
in muscularity.
Ultrasound technology has proven to be useful in helping predict carcass
composition using objective measurements at various stages in the feeding period without
having to utilize serial harvest methods. Ultrasound systems have allowed researchers
and producers to estimate backfat thickness quickly, which is vital because backfat has
been recognized as the single best parameter for estimating carcass yield grade and
composition. Because backfat thickness increases at definite rates, it can be useful to
project future cutability grades, especially in research protocols (Brethour, 1992).
Additionally, ultrasound technology has been found to be reliable and accurate, with
carcass and ultrasound traits positively correlated in a moderate to high magnitude (r=
0.76-0.93; Brethour, 1992). Aside from predicting carcass composition or yield at a
certain time point, ultrasound technology can be used to sort and select cattle prior to the
finishing phase to better predict an optimal endpoint (Basarab et al., 1999). However,
ultrasound technology doesn’t come without some limitations, and may underestimate
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backfat thickness in fatter cattle and overestimate fat thickness in leaner cattle (Williams,
2002) and is time and labor intensive.
Basarab et al. (1999) evaluated the effect of sorting by weight or sorting by a
system that utilizes a combination of weight, ultrasound backfat thickness and marbling
score, on the subsequent effects of performance and carcass merit. The author found that
using a sorting system utilizing parameters estimated from ultrasound technology
clustered cattle into more uniform feeding and marketing groups prior to the finishing
phase. In addition, the more uniformly sorted cattle showed positive effects on growth,
feed efficiency, and carcass yield and quality grades. With these observed benefits, the
author estimated that ultrasound technology could increase profitability by greater than
$21.44 per head.
Unfortunately, the cost of implementation, labor of licensed technicians, and
repeatability of measurements remain major barriers. Houghton and Turlington (1992)
defined the two biggest limitations of the repeatability of ultrasound as the population
variation influence on correlation coefficients (either over- or underestimating),
correlation coefficients not describing bias from different techniques, technicians or other
sources, and producers not appropriately understanding how to interpret correlation
coefficients. The authors also reported that there can be much variation in ultrasound
results caused by differences in hide thickness, hair, and degree of fat at the point of
ultrasound measurements. Williams (2002) reported that backfat measurements using
ultrasound were more reliable because they were one dimensional, whereas LM area is on
different planes. Ultrasound also requires clipping of hair at the point the measurement is
to be taken, application of oil, and multiple measurements to predict LM area and
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backfat, which is added time and expense in addition to the training or hiring of a
certified technician. MacDonald et al (2006) suggested that the cost of implementing
ultrasound is minimal on a per head basis if a large number of animals are measured, but
if a fewer number of animals are ultrasounded late in the finishing phase, potential
performance decreases may become cost inhibiting. While subjective and objective
measurements have been useful in sorting cattle into more uniform marketing groups,
there may be simpler and cost-effective methods to predicting carcass composition and
ideal marketing times.
Importance of Weight
As previously discussed, researchers frequently want to determine the differences
in carcass composition among live animals or carcasses on different treatments, but
sacrificing live animals is not always a feasible option (Hedrick, 1983). Therefore, it has
been accepted that weight has the most impact among measurable variables in predicting
carcass composition in a live animal and can explain up to 60% of the variation in ADG
throughout the animal’s lifetime (Hammock and Shrode, 1986; Feuz, 2002).
Simpfendorfer (1974) summarized the relationship and impact of BW on carcass
composition of British beef breeds from birth through maturity. The author found that
cattle with similar mature sizes, 95.6 to 98.9% of variation in chemical components and
empty body energy of the carcass was accounted for by variation in body weight. This
relationship has allowed for the formulation of different equations and computer models
that account for the variation of BW on final carcass composition (NASEM, 2016). Perry
and Fox (1997) utilized 120 steers representing different breeds to further determine a set
of predictive equations to depict carcass fat percentage and yield grade in live cattle to
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optimize sale points. Steers were fed to reach a carcass endpoint of 275, 300 or 360 kg.
Live carcass measurements were taken using ultrasound and carcass measurements were
taken at a commercial harvesting facility after a 24-h chill. Using these measurements,
the authors were able to construct a set of equations that predict carcass and empty body
composition, which allows for producers to determine incremental cost of gain and
predict quality and yield grade to optimize the conditions in which cattle are marketed.
Cooper et al. (1999) found a relatively strong correlation (r = 0.46 to 0.86)
between weight at reimplant and HCW, which allows for the ability to potentially
identify overweight carcasses at the time of reimplant. While manual palpation or
ultrasound was successful in predicting carcass weight in this trial, identifying yield
grade concerns and estimating back fat was not successful. The author concluded that
ultrasound accounted for 15 to 25 percent of the variation in carcass fat thickness, while
manual rib palpation explained between 5 and 12 percent of carcass fat variation.
MacDonald et al. (2006) demonstrated through different sorting systems that
cattle that were sorted based on BW prior to the finishing phase and then marketed at
different end points based on BW were more successful than other more expensive
sorting methods. The author suggested that sorting on BW alone likely allows producers
to reduce discounts on overweight carcasses and feed lighter animals for more days to
gain additional HCW.
Overall, BW has been shown to be a feasible and accurate measurement to predict
optimal HCW and marketing date. It is the easiest, and potentially most cost effective,
measurement to obtain that can provide the most application to feed yard personnel.
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Conclusions
Exogenous steroid implants have been approved and extensively used in the
feedlot industry over the last 50 years. Nearly all cattle entering the feedlot receive at
least one implant during the finishing phase. These implants help cattle increase the
amount of protein deposited and HCW, and delays the rate of fattening, therefore,
increasing yield grade and potentially decreasing quality grade. Additionally, implants
improve feed efficiency and ADG. There are many different options feedlots can use and
adapt to fit their implant program, therefore giving them the flexibility to find a program
that fits their goals and maximizes their return on investment (Nichols et al., 2009). With
the increases in performance and HCW, implants allow feedlots to sell more total retail
product, potentially making the supply chain more profitable.
In addition to implants, serial harvest studies have helped with understanding how
cattle deposit protein and fat relative to DOF. As cattle are fed longer DOF, ADG and
feed efficiency decrease, while live BW and HCW increase. This allows more saleable
product, which, in general, minimizes the costs associated with feeding extra DOF.
The beef industry is constantly evolving and adopting innovative technology to
increase efficiency and profitability of fed cattle while also feeding for longer DOF when
market conditions allow. Therefore, the objectives of these studies were: to evaluate the
effects of coated long-acting, delayed release implants in heifers fed for constant DOF or
the effect of traditional, aggressive implant strategies compared to long lasting implants
when heifers are fed varying DOF (Exp. 1 and 2) and evaluate and define the optimal
time to reimplant heifers and steers following a mild initial implant (Exp. 3 and 4).

38

LITERATURE CITED
Bartle, S. J., R. L. Preston, R. E. Brown and R. J. Grant. 1992. Trenbolone
acetate/estradiol combinations in feedlot steers: dose-response and implant carrier
effects. J. Anim. Sci. 70:1326-1332.
Basarab, J. A., J. R. Brethour, D. R. ZoBell, and B. Graham. 1999. Sorting feeder cattle
with a system that integrates ultrasound backfat and marbling estimates with a
model that maximizes feedlot profitability in value-based marketing. Can. J.
Anim. Sci. 79: 327-334.
Berg, R. T. and R. M. Butterfield. 1968. Growth patterns of bovine muscle, fat and bone.
J. Anim. Sci. 27: 611-619.
Blasi, D. A., D. M. Henricks, J. S. Drouillard, G. L. Kuhl, and M. F. Spire. 2000.
Characterization of serum hormone profiles in growing heifers implanted with
anabolic growth promotants. Pages 80-83 in Cattlemen’s Day Proceedings.
Kansas. Agric. Exp. Stn. Research Reports.
Botts, R., P. Anderson, K. DeHaan. 1997. Growth stimulants: compounds,
concentrations, combinations, and regulations. In: Proc. Symp. Impact Implants
Perform. Carcass Value Beef Cattle, Oklahoma State Univ., Stillwater, OK. P. 1014.
Brandt, R. T. 1997. Factors affecting release rates and blood levels of hormones from
steroidal implants. In: Proc. Symp. Impact Implants Perform. Carcass Value Beef
Cattle. Oklahoma State Univ., Stillwater, OK. P. 34-39.
Brethour, J. R. 1992. The repeatability and accuracy of ultrasound in measuring backfat
of cattle. J. Anim. Sci. 70: 1039-1044.
Bruns, K. W. and R. H. Pritchard. 2003. Sorting cattle – a review. S. Dakota Beef Rep.
Beef 2003-10:60-69.
Bryant, T. C., T. E. Engle, M. L. Galyean, J. J. Wagner, J. D. Tatum, R. V. Anthony, and
S. B. Laudert. 2010. Effects of ractopamine and trenbolone acetate implants with
or without estradiol on growth performance, carcass characteristics, adipogenic
enzyme activity, and blood metabolites in feedlot steers and heifers. J. Anim. Sci.
88: 4102-4119.
Cady, S. M., C. Macar, and J. W. Gibson. 2002. Extended release growth promoting two
component composition. US. Patent 6,498,153, filed March 22, 1999 and issued
December 24, 2002.
Dayton, W. R. and M. E. Wright. 2014. MEAT SCIENCE AND MUSCLE BIOLOGY
SYMPOSIUM – Role of satellite cells in anabolic steroid-induced muscle growth
in feedlot steers. J. Anim. Sci. 92:30-38.
Dolezal, H. G., J. D. Tatum, and F. L. Williams, Jr. 1993. Effects of feeder cattle frame
size, muscle thickness and age class on days fed, weight, and carcass composition.
J. Anim. Sci. 71: 2975-2985.

39

Duckett, S. K. and J. G. Andrae. 2001. Implant strategies in an integrated beef production
system. J. Anim. Sci. 79 (E. Suppl.): E110-117.
Duckett, S. K., F. N. Owens, and J. G. Andrae. 1997. Effects of implants on performance
and carcass traits of feedlot steers and heifers. In: Proc. Symp. Impact Implants
Perform. Carcass Value Beef Cattle. Oklahoma State Univ., Stillwater, OK. P. 6382.
Enright, W. J., J. F. Quirke, P. D. Gluckman, B. H. Breier, L. G. Kennedy, I. C. Hart, J.
F. Roche, A. Coert, and P. Allen. 1990. Effects of long-term administration of
pituitary-derived bovine growth hormone and estradiol on growth in steers. J.
Anim. Sci. 68: 2345-2356.
Feuz, D. 2002. A stimulated economic analysis of altering days on feed and marketing
cattle on specific value-based pricing grids. NE Beef Report. P 39-41.
Galbraith, H. 1980. The effect of trenbolone on acetate growth, blood hormones and
metabolites, and nitrogen balance of beef heifers. Anim. Prod. 30: 398-394.
Guiroy, P. J., L. O. Tedeschi, D. G. Fox, and J. P. Hutcheson. 2002. The effects of
implant strategy on finished body weight of beef cattle. J. Anim. Sci. 80: 17911800.
Haecker, T. L. 1915. The composition of steers. J. Anim. Sci. 1915:18-25.
Hammack, S. P. and R. R. Shrode. 1986. Calfhood weights, body measurements and
measures of fatness versus criteria of overall size and shape for predicting
yearling performance in beef cattle. J. Anim. Sci. 63: 447-452.
Hedrick, H. B. 1983. Methods of estimating live animal and carcass composition. J.
Anim. Sci. 57:1316-1327.
Henricks, D. M., R. T. Brandt, E. C. Titgenmeyer, and C. T. Milton. 1997. Serum
concentrations of trenbolone-17β and estradiol-17β and performance of heifers
treated with trenbolone acetate, melengestrol acetate, or estradiol-17β. J. Anim.
Sci. 75: 2627-2633.
Hicks, R. B., F. N. Owens, D. R. Gill, J. J. Martin, H. G. Dolezal, F. K. Ray, V. S. Hays,
and C. A. Strasia. 1987. The effect of slaughter date on carcass gain and
characteristics of feedlot steers. Okla. State Univ. Anim. Sci. Res. Rep. MP119:351-358.
Hilscher Jr., F. H., M. N. Streeter, K. J. Vander Pol, B. D. Dicke, R. J. Cooper, D. J.
Jordon, T. L. Scott, A. R. Vogstad, R. E. Peterson, B. E. Depenbusch, and G. E.
Erickson. 2016. Effect of increasing initial implant dosage on feedlot performance
and carcass characteristics of long-fed steer and heifer calves. Prof. Anim. Sci. 32:
53-62.
Houghton, P. L. and L. M. Turlington. 1992. Application of ultrasound for feeding and
finishing animals: a review. J. Anim. Sci. 70: h930-941.

40

Istasse, L., P. Evrard, C. Van Eenaeme, M. Gielen, G. Maghuin-Rogister and J. M.
Bienfait. 1988. Trenbolone acetate in combination with 17β-estradiol: influence
of implant supports and dose levels on animal performance and plasma
metabolites. J. Anim. Sci. 66: 1212-1222.
Jennings, M. A. 2012. Interaction of Optaflexx and terminal implant window on growth
performance and carcass characteristics in heifers fed to harvest. Thesis. Texas
Tech University.
Johnson, B. J., P. T. Anderson, J. C. Meiske, and W. R. Dayton. 1996. Effect of
combined trenbolone acetate and estradiol implant on feedlot performance,
carcass characteristics, and carcass composition of feedlot steers. J. Anim. Sci. 74:
363-371.
Johnson, B. and J. Beckett. 2014. Application of growth enhancing compounds in
modern beef production. Am. Meat Sci. Assn. Ref. Paper. September 2014.
Johnson, B. J. and K. Y. Chung. 2007. Alterations in the physiology of growth of cattle
with growth-enhancing compounds. Vet Clin. Food Anim. 23: 321-332.
Johnson, B. J., F. R. B. Ribeiro, and J. L. Beckett. 2013. Application of growth
technologies in enhancing food security and sustainability. Anim. Frontiers. 3: 813.
Kamanga-Sollo, E., M. E. White, M. R. Hathaway, K. Y. Chung, B. J. Johnson and W. R.
Dayton. 2008. Roles of IGF-1 and the estrogen, androgen and IGF-1 receptors in
estradiol-17β- and trenbolone acetate-stimulated proliferation of cultured bovine
satellite cells. Dom. Anim. Endoc. 35: 88-97.
Koch, R. M., M. E. Dikeman, D. M. Allen, M. May, J. D. Crouse, and D. R. Campion.
1976. Characterization of biological types of cattle III. Carcass composition,
quality and palatability. J. Anim. Sci. 43:48-62.
MacDonald, J. C., T. J. Klopfenstein, G. E. Erickson, C. N. Macken, J. D. Folmer, and
M. P. Blackford. 2006. Sorting strategies for long yearling cattle grown in an
extensive forage utilization beef production system. Prof. Anim. Sci. 22: 225-235.
MacDonald, J. C., T. J. Klopfenstein, G. E. Erickson, K. J. Vander Pol. 2007. Changes in
gain through the feeding period. NE Beef Report. P 55-57.
Mader, T. L. Carryover and lifetime effects of growth promoting implants. In: Proc.
Symp. Impact Implants Perform. Carcass Value Beef Cattle, Oklahoma State
Univ., Stillwater, OK, P. 88-94.
Meyer, H. H. D. 2001. Biochemistry and physiology of anabolic hormones used for
improvement of meat production. APMIS 109: 1-8.
NASEM. 2016. Nutrient Requirements of Beef Cattle. 8th Revised Edition. National
Academies Press, Washington, D. C.

41

Nichols, C. A. 2009. Effects of new extended release implant and feeding a combination
of dry milling byproducts on finishing steer performance and carcass
characteristics. M.S. thesis. Univ. of Nebraska, Lincoln.
Nichols, W. T., M. L. Galyean, D. U. Thomson, and J. P. Hutcheson. 2002. Review:
Effects of steroid implants on the tenderness of beef. Prof. Anim. Sci. 18: 202-210
Oney, C. R., M. N. Streeter, W. T. Nichols, B. D. Dicke, R. J. Cooper, D. J. Jordon, T. L.
Scott, E. Larson, S. M. McNeley, R. C. Raymond, G. E. Erickson and A. K.
Watson. 2018. Impact of utilizing increasingly aggressive implant protocols on
feedlot performance and carcass characteristics of calf-fed steers. Prof. Anim. Sci.
Accepted.
Pampusch, M. S., M. E. White, M. R. Hathaway, T. J. Baxa, K. Y. Chung, S. L. Parr, B.
J. Johnson, W. J. Weber, and W. R. Dayton. 2008. Effects of implants of
trenbolone acetate, estradiol, or both, on muscle insulin-like growth factor-I,
insulin-like growth factor-I receptor, estrogen receptor-α, and androgen receptor
messenger ribonucleic acid levels in feedlot steers. J. Anim. Sci. 86: 3418-3423.
Parr, S. L., T. R. Brown, F. R. B. Riberio, K. Y. Chung, J. P. Hutcheson, B. R. Blackwell,
P. N. Smith, and B. J. Johnson. 2014. Biological responses of beef steers to
steroidal implants and zilpaterol hydrochloride. J. Anim. Sci. 92: 3348-3363.
Parr, S. L., B. J. Johnson, et al. 2011. Performance of finishing beef steers in response to
anabolic implant and zilpaterol hydrochloride supplementation. Plains Nutrition
Conference Proceedings. P 75-76.
Perry, T. C. and D. G. Fox. 1997. Predicting carcass composition and individual feed
requirement in live cattle widely varying in body size. J. Anim. Sci. 75: 300-307.
Preston, R. L. 1999. Hormone containing growth promoting implants in framed livestock.
Adv. Drug. Del. Reviews. 38: 123-138.
Raun, A. P. and R. L. Preston. 2002. History of diethylstilbestrol use in cattle. ASAS. P.
1-7.
Reinhardt, C. 2007. Growth-promotant implants: managing the tools. Vet Clin. Food
Anim. 23: 309-313.
Simpfendorfer, S. 1974. Relationship of body type, size, sex, and energy intake to the
body composition of cattle. Ph.D. Dissertation. Cornell University, Ithaca, NY.
Steen, R. W. J., and D. J. Kilpatrick. 1995. Effects of plane of nutrition and slaughter
weight on the carcass composition of serially slaughtered bulls, steers, and heifers
of three beef crosses. Livestock Prod. Sci. 43: 205-213.
Streeter, M. N., J. P. Hutcheson, W. T. Nichols, D. A. Yates, J. M. Hodgen, K. J. Vander
Pol, and B. P. Holland. 2012. Review of large pen serial slaughter trials- growth, carcass characteristics, feeding economics. Plains Nutrition Council Proceedings,
Texas Agrilife Research and Extension Center, Amarillo, TX. P. 58-72.

42

Tatum, J.D., F. L. Williams, Jr. and R. A. Bowling. 1986. Effects of feeder-cattle frame
size and muscle thickness on subsequent growth and carcass development. I. An
objective analysis of frame size and muscle thickness. J. Anim. Sci. 1986. 62:
109-120.
Trenkle, A. 2007. Mechanisms of action of estrogens and androgens on performance of
cattle – hormonal basis. In: Proc. Symp. Impact Implants Perform. Carcass Value
Beef Cattle, Oklahoma State Univ., Stillwater, OK., P. 15-22.
Van Koevering, M. T., D. R. Gill, F. N. Owens, H. G. Dolezal, and C. A. Strasia. 1995.
Effect of time on feed on performance of feedlot steers, carcass characteristics,
and tenderness and composition of Longissimus muscles. J. Anim. Sci. 73: 21-28.
Vasconcelos, J. T. and M. L. Galyean. 2007. Nutritional recommendations of feedlot
consulting nutritionists: The 2007 Texas Tech University survey. J. Anim. Sci.
85: 2772-2781.
Vasconcelos, J. T., R. J. Rathmann, R. R. Reuter, J. Leibovich, J. P. McMeniman, K. E.
Hales, T. L. Covey, M. F. Miller, W. T. Nichols, and M. L. Galyean. 2008.
Effects of duration of zilpaterol hydrochloride feeding and days on the finishing
diet of feed lot cattle performance and carcass traits. J. Anim. Sci. 86: 2005-2015.
Wheeler, T. L., L. V. Cundiff, S. D. Shackelford, and M. Koohmaraie. 2005.
Characterization of biological types of cattle (Cycle VII): Carcass, yield and
logissimus palatability traits. J. Anim. Sci. 83: 196-207.
Wilken, M. F., J. C. MacDonald, G. E. Erickson, T. J. Klopfenstein, C. J. Schneider, K.
M. Luebbe, and S. D. Kachman. 2015. Marketing strategy influences optimum
marketing date of steers in relation to corn price and days on feed. Prof. Anim.
Sci. 31: 224-236.
Williams, A. R. 2002. Ultrasound applications in beef cattle carcass research and
management. J. Anim. Sci. 80 (E. Suppl. 2):E183-E188.
Zinn, D. W., R. M. Durham, and H. B. Hedrick. 1970. Feedlot and carcass grade
characteristics of steers and heifers as influenced by days on feed. J. Anim. Sci.
21: 302-306.

43

CHAPTER II. Evaluation of coated steroidal combination implants on performance
and carcass characteristics of finishing heifers fed for constant or varying days on
feed

C. A. Ohnoutka*, R. G. Bondurant*, B. M. Boyd*, F. H. Hilscher*, B. L. Nuttelman†, G.
I. Crawford†, M. N. Streeter†, M. K. Luebbe*, J. C. MacDonald*, Z. K. Smith‡, B. J.
Johnson‡, and G. E. Erickson*

*Department of Animal Science, University of Nebraska, Lincoln 68583; †Merck Animal
Health, DeSoto, KS 66018; and ‡ Department of Animal and Food Sciences, Texas Tech
University, Lubbock, TX 79409

44

Abstract
Two experiments evaluated the effect of delayed and long-lasting implant
strategies for finishing heifers. In Exp. 1, heifers (n=500; initial BW = 280; SD = 21 kg;
10 pens/treatment) were utilized in a generalized randomized block design to evaluate the
effects of coated trenbolone acetate (TBA) and estradiol (E2) implants (Merck Animal
Health, De Soto, KS) on growth performance, carcass characteristics, and serum
metabolites when heifers are fed for 198 d. The five treatments included no implant
(CON), Revalor-XH on d 1 (200 mg TBA/20 mg E2, partially coated; XH), Revalor-200
on d 1 (200 mg TBA/20 mg E2, noncoated; E200), Revalor-XR on d 1 (200 mg
TBA/20mg E2, coated; XR) or Revalor-200 on d 70. (D200). Blood was collected on d 1,
35, 70, 105, 140, and 175 and sera was harvested for further analysis of blood urea-N
(BUN), IGF-1, 17β-trenbolone (17β-TbOH) and NEFA concentrations. Implanted heifers
were heavier, gained more, and were more efficient (P ≤ 0.03) compared to CON, but no
differences were observed between implant treatments (P ≥ 0.21). Implanted heifers had
greater HCW and dressing percent, but lower marbling scores compared to CON (P ≤
0.04), with no differences between implant treatments (P ≥ 0.38). Blood urea-N levels
increased as days on feed (DOF) increased (P < 0.01), NEFA levels decreased as DOF
increased (P < 0.01), and IGF-1 levels increased as DOF increased (P < 0.01), regardless
of implant treatment. There was an implant × time interaction (P < 0.01) for 17β-TbOH
respective to the implant’s release pattern and payout. In Exp 2., calf-fed heifers (n = 720;
initial BW = 281; SD= 10 kg; 6 pens/treatment) were utilized in a 3 × 4 factorial
arrangement with 3 implant strategies and 4 serial harvest dates. Implant treatments
included no implant (CON), Revalor-200 on d 1 followed by Revalor-200 on d 100
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(200), or Revalor-XH (XH) on d 1. Serial harvest days included 151, 165, 179, and 193
DOF. There were no serial harvest × implant treatment interactions (P ≥ 0.23) for growth
performance or carcass characteristics (P ≥ 0.31). Final BW increased linearly (P < 0.01)
ADG tended to decrease linearly (P = 0.10), and G:F decreased linearly (P = 0.02). Fat
depth, marbling score, and yield grade increased linearly (P < 0.01) as DOF increased.
Implanted heifers had heavier HCW, gained more, and were more efficient compared to
CON (P ≤ 0.04). Non-implanted heifers had greater USDA marbling score (P < 0.01)
compared to implanted cattle, and XH tended to have a greater marbling than 200 (P =
0.10). Implanting and increasing DOF substantially increased HCW but increasing initial
implant dosage did not result in a performance advantage when heifers were fed for
varying DOF.
Keywords: Implants, Payout, Serial Harvest
Introduction
Growth promoting implants have been proven to be a safe and effective tool in the
feedlot industry to increase gain and hot carcass weights in steers and heifers (Duckett et
al., 1997; Bruns et al., 2005; Folmer et al., 2009). Implants obtain this response by
increasing frame size and delaying fattening, which requires cattle to be fed to longer
days on feed (DOF) to achieve similar empty body fat percentage as non-implanted cattle
(Reinhardt, 2007; Smith et al., 2017).
Traditional, uncoated combination implants have a payout period of 60 to 120 d
(Mader, 1998), which then requires reimplantation if cattle are fed for over 120 d. More
recently, beef producers have been feeding for longer DOF, which can cause logistical
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issues for reimplanting strategies. The FDA has approved coated implants in the last
decade that can be used for cattle fed for 200 d post implantation. Coating technology on
these implants can delay the partial or entire dose of steroids until approximately 70 to 80
d after implantation, which can deliver similar performance as a traditional initial implant
given on arrival followed by a terminal implant approximately 100 d prior to slaughter.
For example, Nichols et al. (2014) reported no differences in final BW, ADG, G:F or
carcass characteristics for steers given either an initial implant + terminal implant or one
partially coated implant of the same hormonal concentration and fed for 157 d. Therefore,
the objective of this study was to evaluate feedlot and carcass performance of long-fed
heifers given new partially-coated (Revalor-XH) or fully coated (Revalor-XR) implant
program, compared to traditional implant strategies or no implant and fed for similar or
varying DOF.
Materials and Methods
All procedures used in these experiments were reviewed and approved by the
University of Nebraska- Lincoln Institutional Animal Care and Use Committee (IACUC).
Experimental Design and Procedures: Exp. 1
Crossbred heifers (n = 500; initial BW = 280; SD = 21 kg) were utilized in a
generalized randomized block design with 2 initiation blocks and 2 BW blocks within
start time. Heifers were assigned randomly to one of 50 pens (10 heifers/pen) and pens
were assigned randomly to one of five treatments. Treatments included: no implant
(CON), Revalor-XH on d 1 [200 mg trenbolone acetate (TBA) and 20 mg estradiol (E2),
partially coated (XH); Merck Animal Health, DeSoto, KS], Revalor-200 on d 1 (200 mg
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TBA/20 mg E2, Merck Animal Health, noncoated; E200), Revalor-XR on d 1 (200 mg
TBA/20mg E2; Merck Animal Health, coated; XR) or Revalor-200 on d 70 (200 mg
TBA/20 mg E2; Merck Animal Health, noncoated; D200). All implants contained 10
pellets (20 mg TBA/2 mg E2 per pellet), but coating technology varied among implants.
Revalor-XR contained 10 coated pellets that are designed to be released approximately
70 to 80 days after implanting. Revalor-XH contains four uncoated pellets (80 mg TBA
and 8 mg E2) for immediate release and 6 coated pellets (120 mg TBA and 12 mg E2) to
release approximately 70 to 80 d after implanting.
Heifers were sourced from auction markets and transported to the University of
Nebraska Eastern Research and Extension Center (ENREC) research site located near
Mead, NE. At the time of feedlot arrival, all heifers were individually identified (panel
tag, electronic button, and metal clip). All heifers received an infectious bovine
rhinotracheitis (IBR) virus, parainfluenza-3 (PI3) virus, bovine viral diarrhea (BVD) virus
(types I and II), bovine respiratory syncytial virus (BRSV), Mannheimia haemolytica and
Pasteurella multocida combination vaccine (Vista Once, Merck Animal Health), a
Clostridium chauvoei, specticum, novyi, sordellii, perfringens Types B, C, and D
bacterin-toxoid (Vision 7, Merck Animal Health), a 10 percent fenbendazole oral
suspension for the control of lung worms, stomach worms, and intestinal worms (SafeGuard Dewormer, Merck Animal Health), a synthetic prostaglandin to induce luteolysis
(Estrumate, Merck Animal Health), and one percent doramectin injectable for treatment
and prevention of gastrointestinal and external parasite control (Dectomax, Zoetis Inc.,
Florham Park, NJ).
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Before initiation of the trial, heifers were limit fed at 2% of BW for 5 d a diet
consisting of 50% Sweet Bran (Cargill Corn Milling, Blair, NE) and 50% alfalfa hay
(DM basis) to minimize variation in gastrointestinal fill (Watson et al., 2013). Heifers
were weighed (Silencer Squeeze Chute; Moly Mfg. Inc., Lorraine, KS: scale readability ±
0.45 kg) two consecutive days (d 0 and 1) to establish initial BW. Heifers were blocked
by d 0 BW (light and heavy), stratified by BW within blocks and assigned randomly to
pen within block. Initiation of trial was also used as a block, with 2 starting dates 1 week
apart and 25 pens starting each week. Pens were assigned randomly to one of five
treatments with 10 pens per treatment. Light and heavy blocks consisted of four
replications and one replication, respectively, for block one and one replication and four
replications, respectively, for block two. On d 1 (May 20, 2016 for block 1 and May 27,
2016 for block 2) heifers were implanted with their respective treatment. Implants were
administered in the middle one-third of the ear using a Revalor implant gun (Merck
Animal Health). Sentinel heifers (n = 3 heifers/pen; 30 heifers/treatment) were identified
prior to initiation of the study based on the average of the d 0 and d 1 BW measurements.
The 3 heifers/pen with an average d 0 and d 1 BW closest to the mean BW of their home
pen were selected for blood collection. Blood samples were taken via tail venipuncture
from sentinel heifers prior to feeding on d 1, 35, 70, 105, 140 and 175 using BD
Vacutainer Serum collection tubes (BD, Franklin Lakes, NJ). If tail venipuncture was
unsuccessful, jugular venipuncture was used. Whole blood samples were allowed to clot
at 4° C for 24 h prior to sera harvest to be used for quantifying circulating concentrations
of blood urea-N (BUN), non-esterified fatty acid concentration (NEFA), IGF-1, and 17β-
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TbOH. On blood collection days, cattle were also individually weighed in the morning
prior to feeding to establish interim performance.
All heifers were adapted to a common finishing diet over a 24-d period consisting
of four adaptation diets. The amount of wet distiller’s grains (WDGS), Sweet Bran, and
supplement were held constant at 15%, 25% and 4% (DM basis) of the diet, respectively.
The amount of dry rolled corn (DRC) and high moisture corn (HMC) were gradually
increased while replacing alfalfa. The first adaptation diet consisted of 11% DRC, 0%
HMC, and 45% alfalfa hay and was fed for 5 d. The second adaptation diet was fed for 5
d and consisted of 18.3% DRC, 2.8% HMC and 35% alfalfa hay. The third adaptation
diet included 23.3% DRC, 7.7% HMC and 25% alfalfa hay and was fed for 7 d. The
fourth and final adaptation diet included 28.3% DRC, 12.7% HMC, and 15% alfalfa hay
and was fed for 7 d. The finishing diet included 32.3% DRC, 16.2% HMC, and 7.5%
grass hay, replacing alfalfa hay.
Heifers were housed in open feedlot pens with approximately 91 cm of linear
bunk space and 56 m2 pen space per heifer. Feed bunks were assessed once daily at
approximately 0600 for presence of feed. Feed amounts were increased or decreased
daily to maintain an ad libitum bunk management approach. Cattle were fed once daily
between 0700 and 0900 and had ad libitum access to fresh water and respective diet.
Diets were mixed and delivered using a truck-mounted feed mixer and delivery unit
(Roto-Mix model 420, Roto-Mix, Dodge City, KS). Weekly samples of ingredients were
collected by University personnel, composited by month, and sent to a commercial
laboratory (Ward Laboratories, Inc., Kearney, NE) to determine CP (Padmore, 1990a;
Padmore, 1990b; Gavlak et al., 1996, LECO Corporation), NDF (Mertens, 1992;
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ANKOM Technology, 1996; ANKOM Technology, 1998), calcium (Campbell and
Plank, 1991; Kovar, 2003), and phosphorus (Campbell and Plank, 1991; Wolf et al.,
2003; Kovar, 2003) content of individual ingredients. When refusals were present, orts
were weighed, sampled and frozen for later analysis of DM. Dry matter of orts were
determined by placing samples in a 60° C forced-air oven for 48 h (AOAC Method
935.29; AOAC, 1999). Cattle were visually evaluated daily by trained UNL personnel.
Evaluations include proper functionality of water tanks, integrity of fences and feed
bunks, and any abnormal behavior of the cattle. When heifers were determined to be sick,
heifers were removed from the pen and taken to the processing facility for diagnosis and
appropriate treatment and then returned to their home pen.
On day of shipping, heifers were offered 50% of the previous day’s called feed.
In the afternoon, all heifers were brought to the handling facility, pen weighed to
determine final live BW, and loaded onto trucks. All animals were harvested at a
commercial harvest facility (Greater Omaha Packing, Omaha, NE) after 194 d (Block 1)
or 201 d (Block 2) on feed. Hot carcass weight and liver scores were recorded on day of
harvest. After a 48-h chill, LM area, 12th rib fat thickness, and USDA marbling score
were recorded. Yield grade was calculated (USDA, 2016) from the following formula:
2.5 + (0.98425 x 12th rib fat, cm) + (0.2 x 3.0 [KPH, %]) + (0.00837 x HCW, kg) –
(0.0496 x LM area, cm2). Live final BW was pencil shrunk 4% to calculate dressing
percentage and live performance. A common dressing percentage of 63% was used to
calculate carcass adjusted final BW, ADG, and G:F.
Serum Metabolite Analysis
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Whole blood samples were centrifuged at 1,250 × g for 20 min at 4 degrees C.
Serum was then harvested from each tube and approximately 2 mL allocated in one of
three tubes. Two tubes were then frozen at -20° C for later analysis of blood urea-N
(BUN) and non-esterified fatty acids (NEFA). One tube was frozen at -80° C for analysis
of 17β-TbOH and IGF-1 concentrations.
Urea-N was analyzed using sera by animal and day using an adapted procedure
from Smith and Murphy (1993) and quantified using spectrometry and fitted to a standard
dilution curve. Standard dilution curve was between 0 and 30 mg/dL. Samples were run
in duplicate and considered for re-runs if the coefficient of variation between duplicates
was greater than 10%. Non-esterified fatty acid was analyzed using an in vitro enzymatic
colorimetric method assay (HR Series NEFA-HR, Wako Pure Chemical Industries, Ltd.,
Mountain View, CA) and quantified using spectrometry fitted to a standard dilution
curve. The standard dilution curve was constructed from values ranging from 0 to 1000
µeq/L. Samples were run in duplicate and considered for reruns if the CV coefficient was
greater than 10%.
Circulating sera IGF-1 was quantified via ELISA (Quantikine Human IGF-I
ELISA, R & D Systems, Minneapolis, MN). The IGF-I assay was analyzed using sera
pooled by pen and day. Prior to analysis raw sera samples were extracted to reduce IGF
binding protein interference. The standard curve constructed for the IGF-I assay was
between 9.4 and 600.0 ng/mL. Samples were run in duplicate and determinations were
considered for re-runs if the CV between duplicate samples were greater than 10%.
Circulating 17β-TbOH concentration was quantified via liquid chromatographytandem mass spectrometry (LC-MS/MS) using slight modifications to the
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procedures described by Blackwell et al. (2014). The 17β-TbOH assay was conducted
using sera pooled by pen and day, while, sera from all heifers in CON were pooled by
block and day. In 15 mL conical screw top tubes, equal volumes of methyl-tert-butylether (MTBE) and sera (2 mL) were spiked with 10 ng of internal standard (17βtrenbolone-d3, National Institute for Public Health and the Environment of the
Netherlands), then placed in an orbital shaker at 300 rpm for 30 min at room temperature.
Samples were centrifuged for 5 min at 1500 × g to separate sera and MTBE layers. The
MTBE layer was removed and then transferred to 100 × 16 mm borosilicate glass tubes
and evaporated to dryness at 35°C under a gentle stream of nitrogen. Samples were
reconstituted in 4 mL 80:20 methanol: water (HPLC grade, Fisher Scientific, Hampton,
NH). Next, 3 mL of hexane (HPLC grade, Fisher Scientific) was added to the
reconstituted samples and samples were vortexed for 30 s. Following the vortex step,
samples were centrifuged at room temperature for 5 min at 1500 × g in order to separate
the water: methanol mixture from the hexane layer, the hexane layer (top) was then
discarded, and the hexane wash was repeated. Samples were then dried to a volume of
less than 0.5 mL under a gentle stream of nitrogen at 35°C, and 3 mL of 5:95 methanol:
water + 0.1% ammonium hydroxide was added to each sample prior to SPE
cleanup. Oasis MAX cartridges (3cc/60 mg; Waters Corporation, Milford,
MA) were conditioned with 3 mL of methanol and 3 mL of 5:95 methanol: water + 0.1%
ammonium hydroxide, samples were passed through, and cartridges were washed with 2
× 3 mL 5:95 methanol: water + 0.1% ammonium hydroxide. Cartridges were then
allowed to dry under vacuum for 10 min, and samples were eluted into clean 16 × 100
mm borosilicate glass tubes with 7 mL of methanol. The samples were then evaporated to
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dryness at 35°C under a gentle stream of nitrogen and reconstituted in 100 µL of
60:40 methanol: water. The reconstituted sample was passed through a 0.45
µM polypropylene filter into fixed-insert microvials, capped, and stored at -20°C
until analysis. Blank (n = 3) and spiked (n = 3) matrix (bovine serum, Sigma-Aldrich, St.
Louis, MO) samples were analyzed along with 42 unknowns per sample batch (48
extractions in total) in order to monitor extraction method performance. No steroids were
observed above the limit of detection in any solvent or matrix blank. The mean matrix
spike recovery (n = 18) for sera was (112.3 ± 20.79%)
Quantification of 17β-TbOH was performed via triple quadrupole LCMS/MS (TSQ Endura, ThermoFisher). Chromatography was performed
using a methanol: water gradient elution taken from Blackwell et
al. (2013) and a Gemini-NX C18 column (150 x 2.0mm; Phenomenex, Torrance, CA)
with a sample injection volume of 10 µL. Ionization was performed using atmospheric
pressure chemical ionization in positive mode. Solvent blanks and check standards were
included every 8 and 16 samples, respectively, in instrument runs for quality control
purposes. The limit of quantification, as determined by the lowest calibration standard
included in sample runs, was 25 pg/mL serum. Values below the limit of quantification
were assigned a value of 12.5 pg/mL serum which was half the value of the lowest
calibration standard.
Statistical Analysis: Exp. 1
Animal performance and carcass characteristics were analyzed as a generalized
randomized block design using the MIXED procedure of SAS (Version 9.4; SAS
Institute, Inc., Cary, N.C.) with pen as the experimental unit. Heifers that were removed
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or died during the experiment were not included in the analysis. The model included
treatment and block as fixed effects. Treatment means were separated using LSD test
when the overall F-test was significant. Quality and yield grade distributions were
analyzed using the GLIMMIX procedure of SAS using a multinomial approach.
Blood urea-N, NEFA, 17β-TbOH, IGF-1, and estradiol-17β were analyzed using
the proc GLIMMIX procedure in SAS as a repeated measure. Treatment, time, and
treatment × time interaction was included in the model as fixed effects and block was
treated as a random effect. Treatments were analyzed for differences at time point 0, but
time point 0 was not included in the model. For all variables, alpha values < 0.05 were
considered significant and tendencies were discussed when alpha values were 0.05 ≤ P ≤
0.10.
Experimental Design and Procedures: Exp. 2
A feedlot trial was conducted at the Panhandle Research and Extension Center
near Scottsbluff, NE utilizing 720 crossbred calf-fed heifers (initial BW = 281; SD = 10
kg) arranged in a 3 × 4 factorial design. Heifers were assigned randomly to one of twelve
treatments consisting of three implant strategies and four serial harvest groups. Implant
strategies included a non-implanted negative control (NON), a re-implant strategy
providing an initial implant containing 200 mg trenbolone acetate and 20 mg estradiol
(Revalor-200, Merck Animal Health) followed by another implant containing 200 mg
trenbolone acetate and 20 mg estradiol (Revalor-200, Merck Animal Health) at 100 days
on feed (200/200), and a delayed release implant strategy providing an initial implant
containing 200 mg trenbolone acetate and 20 mg estradiol (Revalor-XH, Merck Animal
Health) at day 0 (XH). The Revalor-XH implant contains ten pellets each with 20 mg
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trenbolone acetate and 2 mg estradiol, including four uncoated pellets (immediate
release) and six coated pellets, which served as the delayed release portion of the implant.
The four serial harvest groups were determined based on time point at which the heifers
reached appropriate market condition, in which serial harvest groups would be marketed
at 14 d intervals thereafter. Based on the performance and time at which marketing
condition was achieved, serial harvest groups consisted of heifers fed to 151 (NORMAL),
165 (PLUS14), 179 (PLUS28), and 193 (PLUS42) days on feed. The trial utilized 72, 10
head pens allowing for six replications per treatment (60 heifers per trt).
On arrival, all heifers were identified and processed. During the identification
process, heifers received a panel tag in the left ear with an individual identification
number and a metal tag in the right ear with corresponding identification number. All
heifers received a Clostridium chauvoei, specticum, novyi, sordellii, perfringens Types B,
C, and D bacterin-toxoid (Vision 7; Merck Animal Health) for prevention of disease
caused by Clostridium chauvoei (Blackleg), septicum (Malignant edema), novyi (Black
disease), sordellii and perfringens Types C&D (Enterotoxemia) and 2 mL Vista Once
subcutaneous (Merck Animal Health) for the prevention of respiratory disease caused by
IBR, BVD (Type 2), and BRSV and as an aid in the control of disease caused by BVD
(Type 1), PI3, Mannheimia haemolytica and Pasteurella multocida. Upon processing on d
0, heifers also received 14 mL fenbendazole oral drench (Safeguard, Merck Animal
Health) for removal and prevention of worms. Heifers were housed in pens and limit fed
until initiation of the trial.
Heifers were limit fed step 1 of the step-up ration at 2% BW per day for 5
consecutive days prior to a 2-d weight collection to minimize variation in gut fill (Watson
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et al., 2013). On d 0 of the trial, individual BW was recorded, carcass ultrasound images
were collected, and heifers were assigned randomly to one of twelve treatments within
three initial start date blocks. Based on treatment assigned, heifers were administered
their respective implant while in the chute on d 0. Each treatment was represented equally
within start date block with two replications per block for a total of 24 pens (240 heifers).
On d 1 of the trial, a pen weight was recorded to serve as the second d weight collection.
Real time carcass ultrasound images were collected on heifers at initiation of trial,
100 d (re-implant), and each d of serial shipping for all heifers remaining (151, 165, 179,
and 193 d). Real time carcass ultrasound measurements including LM area, 12th rib fat
thickness, and intramuscular fat percent were collected by a Centralized Ultrasound
Processing (CUP Lab; Ames, Iowa) certified field technician. Images were captured using
an Aloka 500-V unit (Corormetrics Medical Systems, Wallingford, CT) equipped with a
3.5-MHz, 17.2 cm linear array transducer. All images were captured on the right side of
each heifer. To capture 12th rib fat thickness and LM area, the heifer was palpated to
locate the 13th rib and the transducer was placed laterally between the 12th and 13th ribs
utilizing a standoff guide to capture the image. Images for intramuscular fat percent were
collected by placing the transducer three-fourths the distance from the medial end of the
LM area to the lateral end and horizontally over the 12th and 13th ribs. Ultrasound image
interpretation was conducted by a certified technician at The CUP Lab. After
interpretation, ultrasound intramuscular fat percent was converted to USDA marbling
score utilizing data presented by Wilson et. al. (1999) to allow for comparisons with
carcass data post-harvest.
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During the trial, bunk space was provided at 54.9 linear cm/heifer and pen space
allotted was 6.1 × 4.3 m which equated to 26.2 m2 per heifer. The step-up period
consisted of 21 d including three d on step 1, four d on step 2, seven d on step 3, and
seven d on step 4. The common finishing ration fed to all heifers consisted of 58% dryrolled corn, 7% corn silage, 4% wheat straw, 25% wet distiller’s grains plus solubles, and
6% supplement (DM basis). Heifers were fed once daily and provided ad libitum access
to feed and water throughout the trial.
Statistical Analysis
All data were analyzed using the GLIMMIX procedure of SAS (SAS Institute,
Inc., Cary, N.C.). Pen was included as the experimental unit and start block was included
as a fixed effect. The model included implant treatments, serial harvest, and the
interaction of implant and serial harvest as fixed effects. Treatment × linear serial harvest
and treatment × quadratic serial harvest were analyzed. Due to a significant difference in
initial pen weights among treatments, initial pen weight was considered a possible
covariate and included in the model. If the covariate was determined to be insignificant
(P > 0.10) for that variable, initial pen weight was removed from the model as a
covariate. Pen initial weight was included as a covariate in the model for final and
carcass-adjusted end BW, final and carcass adjusted ADG, final and carcass adjusted
G:F, and HCW. Orthogonal contrasts were used to test linear and quadratic effects of
serial harvest for heifers. Significance was deemed at an alpha value of ≤ 0.05 and
tendencies were discussed when alpha values were 0.05 ≤ P ≤ 0.10.
Results and Discussion
Experiment 1
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Heifers were evaluated for missing or abscessed implants on d 35 and 105 and if
found, were removed from trial. Two heifers were removed for missing implants on d 35
(one from each block) and one from d 105 (Block 1). No abscessed implants were
observed. Additionally, there was 1 death and 5 removals in block 2 (3 footrot, 1 navel
abscess and 1 chronic).
Overall, there was no effect on DMI (P = 0.22; Table 2.1) due to implant
treatments over the entire feeding period, which is consistent with observations from
Duckett et al. (1997) based on DMI as a percentage of on-test BW, potentially suggesting
that slight changes in DMI with the use of implants is driven by the increase in BW
(Reinhardt and Wagner, 2014). Using carcass-adjusted performance, implanted cattle
were 19 kg heavier than CON (P < 0.01), but there were no differences between implant
treatments (P ≥ 0.87). All implanted cattle had 7% greater ADG compared to CON cattle
(P < 0.01) which led to implanted heifers being 4% more efficient (P < 0.01). This
response has been well documented with implant strategies increasing ADG by an
average of 21% and improving feed efficiency by an average 11%, which is greater than
what was observed in the current experiment (Duckett et al., 1997; Wileman et al., 2009;
Johnson et al, 2013). Kreikemeier and Mader (2004) reported similar results and found
that implanted heifers were 11.8 kg heavier, gained 0.108 kg/d more and heifers receiving
a combination implant + melengesterol acetate (MGA) were more efficient than heifers
receiving a single compound implant or no implant. Heifers implanted with XR, E200 or
D200 were the most efficient (P < 0.01), but E200 or D200 were not different than XH (P
> 0.29), and CON was the least efficient (P = 0.01) Comparable results were observed
when live final performance was evaluated.
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Implanted heifers had 11 kg greater HCW than CON (P < 0.01; Table 2.1). This
response is well documented with an average of 18 to 27 kg of added HCW expected
from use of a combination implant (Johnson and Chung, 2007; Johnson et al., 2013;
Reinhardt and Wagner, 2014). There were no differences in HCW, dressing percentage,
fat thickness, or USDA marbling score among all implanted treatments (P ≥ 0.38), but
CON had a lesser dressing percentage and greater marbling scores compared to implanted
heifers (P ≤ 0.04) in this study when heifers were fed for the same DOF. Kreikemeier and
Mader (2004) found no differences in USDA marbling score for heifers given estrogenic
implants, trenbolone acetate implants, or no implant; however, heifers given an
estrogenic + TBA combination implant had lower marbling scores compared to other
treatments. Johnson and Chung (2007) reported no effect of implant treatment on fat
thickness compared to nonimplanted animals fed the same number of days. Heifers
within XH, XR, and D200 treatments showed an increase in LM area (P < 0.01)
compared to cattle implanted with E200 or CON, which translated into a lesser calculated
yield grade (P = 0.04). Previous researchers have suggested that implanting alters
intramuscular fat deposition and composition due to a dilution effect with increasing LM
area (Duckett et al., 1999). Duckett and Andrae (2001) found implanting cattle with an
estrogenic or combination implant reduced marbling score by 4%, but increased LM area
by 3 or 4%, respectively.
There was a tendency for a change in the distribution of quality grade (P = 0.10)
and yield grade (P = 0.07) between implant treatments and CON (Table 2.2). Johnson
and Chung (2007) noted that the use of growth promotant technologies, such as steroidal
implants, shift nutrient use towards lean carcass tissue rather than adipose tissue, which
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leads to 10 to 12% more carcass protein in implanted cattle compared to non-implanted
controls, which could lead to a shift in yield grade distribution. However, Roeber et al.
(2000) reported no differences in final yield grade because the increase in HCW was
offset by the increase in LM area in the calculations used to determine final yield grade.
Roeber et al. (2000) also reported that the percentage of carcasses grading USDA Prime
or Choice ranged from 94.4% in non-implanted control steers to 75% in steers that were
implanted with 200 mg TBA + 28 mg estradiol (Synovex Plus, Zoetis). However, in the
current study, the effect on percent of heifers grading USDA Choice or Prime was
minimal (92.5% CON vs 91.3% all implant treatments).
Interim performance is summarized in Table 2.3. During the first 70 days of the
feeding period, heifers implanted with XH and E200 had greater ADG and were more
efficient (P = 0.01) compared to the other treatments. From days 70 to 140, cattle
implanted with XR or D200 gained more and were more efficient (P < 0.01) than the
other treatments, which is consistent with the delayed release of XR and the delayed
implanting of D200 heifers. From d 140 to d 175, all implanted cattle were heavier than
CON (P < 0.01). Interestingly, from d 140 to the end of the feeding period, the nonimplanted heifers were more efficient (P = 0.01) than all implanted cattle and the nonimplanted heifers gained more than implanted treatments (P = 0.05).
Serum metabolite results are summarized in Table 2.4 and Figure 2.1. There were
no treatment × time interactions (P ≥ 0.59) or treatment effects (P ≥ 0.12) for BUN,
NEFA, or IGF-1 circulating concentrations. Blood urea-N concentration increased as
DOF increased (P < 0.01) from 15.9 mg/dL to 19.2 mg/dL. As DOF increased, NEFA
levels were decreased (P < 0.01) from an initial level of 330.1 mEq/L on d 1 to 166.9
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mEq/L on d 175 across all treatments. Similarly, IGF-1 levels increased over time (P <
0.01) from levels of 50.9 ng/mL at trial initiation to 91.6 ng/mL after 175 d. Smith et al.,
(2018) evaluated sera IGF-1 levels in steers that were implanted with XR, Revalor-XS
(200 mg TBA + 40 mg E2, partially coated; Merck Animal Health), Revalor-200 on d 1
or Revalor-200 on d 70 compared to a non-implanted control. Contrary to Exp. 1,
implanted steers had increased sera IGF-1 steers compared to non-implanted controls
over 213 d, with levels increasing over time. Similarly, Dayton et al. (1997) observed
combination implants increasing circulating IGF-1 concentrations in steers by 40% on d
40 and 35% after 115 DOF compared to steers that were not implanted.
There was an implant treatment × time interaction (P < 0.01) for 17β-TBOh
levels. At trial initiation, all treatments were below the detection limit of the assay (12.5
pg/mL) and had no circulating 17β-TBOh. Heifers in CON had no detectable 17β-TBOh
for the duration of the collections, however, concentrations of 17β-TBOh increased
markedly after implantation or expected release of coated implants. After 35 d on trial,
E200 had circulating 17β-TBOh of 121.2 pg/mL, which was significantly greater than all
other treatments (P ≤ 0.02). However, over the next 35 d period, XR and E200 had the
greatest levels of circulating 17β-TBOh, but they were not different from each other (P =
0.14). There was a tendency for XR to be different than XH (72.6 and 45.9 pg/mL,
respectively; P = 0.06) after 70 DOF. However, on d 105, XR had the greatest circulating
concentration of 17β-TBOh (147.2 pg/mL), which was not statistically different (P =
0.14) from D200, which had a circulating concentration of 103.8 pg/mL. On d 140, XR
and D200 continued to have the greatest circulating concentrations of 17β-TBOh, with no
statistical differences between treatments (102.2 and 63.4 pg/mL, respectively; P = 0.19).
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By d 175, XH had returned to baseline (≤ 12.5 pg/mL), while D200 maintained the
greatest circulating 17β-TBOh concentration at 80.1 pg/mL. These results are comparable
to those reported by Smith et al. (2018). Henricks et al. (1997) reported that heifers who
received Revalor-H (140 mg TBA + 14 mg estradiol; Merck Animal Health) had
increased 17β-TBOh compared to non-implanted heifers until d 84, when all treatments
containing TBA decreased in serum 17β-TBOh, more so in the Revalor-H treatment. This
is consistent with the steroidal composition of the coated portion of XH. There were no
differences between D200 and XR (P = 0.28), and there was no difference between XR
and E200 (P = 0.38) after 175 DOF.
Experiment 2
Initial BW was significant (P < 0.02) and included in the model as a covariate if
deemed significant. The interactions of treatment × serial harvest, treatment × linear
serial harvest, or treatment × quadratic serial harvest were not significant (P ≥ 0.23) for
performance. Implanted heifers had greater final and carcass-adjusted BW compared to
CON (P < 0.01; Table 2.5), but there were no differences between 200/200 and XH (P ≥
0.58). There were no differences in DMI (P ≥ 0.12) among implant treatments. Carcassadjusted ADG was greater for implanted heifers compared to CON (P < 0.01), but there
were no differences between 200/200 and XH (P = 0.55). The increase in ADG from
implanted heifers led to an improvement in feed efficiency (P < 0.01) compared to CON,
and 200/200 tended to be more efficient than XH (P = 0.07). As previously discussed, the
increase in final BW, ADG and G:F observed in implanted heifers compared to nonimplanted heifers has been well documented. However, the lack of statistical significance
between 200/200 and XH may suggest that a more aggressive initial implant is not of
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added benefit. Hilscher et al. (2016) evaluated the effects of an initial implant of RevalorIH (80 mg TBA + 8 mg estradiol), Revalor-H (140 mg TBA + 40 mg estradiol), or
Revalor-200 on heifer growth performance. All treatments received Revalor-200 as a
terminal implant 89 d after initial processing. Similar to the results observed in the
current study, the author found no differences in final BW, DMI, ADG, or G:F (P ≥ 0.14)
regardless of initial implant strategy. Additionally, Oney et al. (2018) found no
differences with increasing implant dose combination on growth performance in calf-fed
steers.
Similar to growth performance, there were no serial harvest × implant treatment
interactions (P ≥ 0.31) for carcass characteristics, however, the interaction of serial
harvest × implant treatment for backfat tended to be linear (P = 0.12). Hot carcass
weight was greater for implanted cattle compared to CON (P < 0.01), but there were no
differences between implant treatments (P = 0.59). There were no differences in dressing
percent, LM area, or calculated yield grade among all treatments (P ≥ 0.48), but there
was a tendency for CON to have less 12th rib fat compared to heifers implanted with
200/200 or XH (P = 0.10). Cattle accrued backfat linearly (P < 0.01; Table 2.6), but at
different rates (P < 0.01) respective to implant treatment. The daily accretion rate for
backfat for non-implanted heifers was 0.000781 (± 0.002251) cm (Figure 2.2). Heifers
implanted with 200/200 deposited BF at a rate of 0.01735 (± 0.002251) cm per day and
the daily fattening rate for XH was 0.01294 (± 0.002251) cm. However, it is important to
note the simple effects are an average over all DOF treatments. Marbling score was
significantly greater (P < 0.01) for CON, with a tendency for XH to have a greater
marbling score than 200/200 (P = 0.10). Similar carcass results were reported by Hilscher
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et al. (2016). The authors found no differences in HCW, LM area, dressing percent, or
12th rib fat among implant treatments, but the mild initial implant (Revalor-IH) had
significantly greater marbling scores compared to the higher concentration, more
aggressive initial implant strategies. Schneider et al (2007) reported no differences in
carcass characteristics that received varying doses of initial implant and Hutcheson et al.
(2002) reported no differences in growth performance over the feeding period but
observed a decrease in marbling score with the use of implants, consistent with our
findings. Therefore, the use of more aggressive initial implants may not provide growth
performance incentives during the finishing phase, therefore potentially making it more
economically sound to use partially-coated, delayed release implants to achieve
comparable growth performance and increased carcass quality as traditional implant
protocols without having to reimplant.
As heifers were fed for longer DOF, final BW increased linearly from 567 to 613
kg (P < 0.01), while live ADG and G:F decreased linearly (P < 0.01; 1.89 kg/d vs 1.72
kg/d; 0.161 vs 0.146). When carcass-adjusted ADG was analyzed, the decrease in ADG
in heifers fed for longer DOF tended to decrease linearly (P = 0.10), with a lower slope
compared to live ADG. Carcass-adjusted final BW increased 19 kg in the first 14-d
harvest period, 29 kg in the next 14-d, and 17 kg in the final 14-d period. Vasconcelos et
al. (2008) reported similar results and observed a linear increase in final BW and a linear
decrease in ADG and G:F as steers were fed for 136 compared to 198 d. As heifers were
fed from 151 to 193 d, HCW increased linearly (P < 0.01) from 351 kg to 392 kg with the
greatest increase in HCW coming from d 165 to 179. There were no differences in
dressing percent (P = 0.49) but there was a linear increase in BF (P < 0.01; Figure 2.2).
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Likewise, USDA marbling score and YG increased linearly as cattle were fed for longer
DOF (P < 0.01). Heifers that were fed for longer DOF tended to have a linear increase in
LM area (P = 0.09). Consistent with our observations, Rathmann et al. (2012) found that
feeding heifers from 127 d to 167 d increased final BW, decreased ADG, and decreased
feed efficiency, while having no effect on DMI. Furthermore, the author reported a 22.2
kg increase in HCW in the first 21 d serial harvest period and a 14.9 kg increase in the
final 19 d harvest period, while also reporting an increase in 12th rib fat thickness,
calculated yield grade, and USDA marbling score as heifers were fed for longer DOF.
Live weight gain to carcass weight transfer was calculated by dividing the HCW
slope for DOF treatment by the live final BW slope for DOF treatment. When calculated,
heifers transferred 89.5% of gain to carcass weight. This means that towards the end of
the feeding period, for every kilogram of additional BW, approximately 0.9 kg of HCW
was added (Wilken et al., 2015). This is slightly less than what Wilken et al. (2015)
concluded in steers, where weight gain transferred to the carcass approached 100% by the
end of the feeding period. In a review by Streeter et al. (2012), the author concluded that
the carcass transfer in heifers was 86.6% after the first 21-d serial harvest period, but then
declined to 65.8% after 42-d serial harvest period.
Overall, implanting heifers with aggressive implants or implants with coating
technology for delayed and extended release had increased carcass-adjusted final BW,
ADG and were more efficient than non-implanted control heifers. However, the release
rate (coated, uncoated, or delayed implant) did not affect performance of heifers fed for
the same DOF (Exp. 1) and a more aggressive initial implant did increase final BW or
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ADG (Exp. 2). As heifers were fed for increasing DOF, final BW increased linearly,
while ADG and G:F decreased linearly, with no interaction with implant type.
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Table 2.1. Performance and carcass characteristics of implanted heifers compared to non-implanted control heifers fed for an average of 198 d (Exp.
1)
Implant Treatment1
CON

XH

E200

Pre-planned Contrasts
XR

D200

SEM

FTest

CON vs
Implant

XH vs
D200

XR vs
D200

Performance
Initial BW, kg
281
281
280
280
280
8.3
1.00
0.94
0.95
Live Final BW, kg
564
581
577
580
577
12.9
0.26
0.03
0.67
2
Adj. Final BW, kg
561
580
580
580
579
12.5
0.09
0.01
0.87
DMI, kg/d
9.7
10.0
9.9
9.8
9.9
0.26
0.22
0.12
0.28
Live ADG, kg
1.44a
1.52b
1.51b
1.52b
1.50b
0.044
0.02
<0.01
0.59
Live G:F
0.148a
0.151a
0.152ab
0.156b
0.153ab
0.0015
0.02
0.01
0.54
2
a
b
b
b
b
Adj. ADG, kg
1.42
1.52
1.52
1.52
1.51
0.039
<0.01
<0.01
0.86
2
a
b
bc
c
bc
Adj. G:F
0.147
0.151
0.153
0.156
0.153
0.0015 <0.01
<0.01
0.29
Carcass characteristics
HCW, kg
354
365
365
365
365
7.9
0.09
<0.01
0.88
Dress, %
62.7
63.1
63.3
63.0
63.2
0.12
0.18
0.04
0.81
LM area, cm2
79.4b
83.9a
80.0b
82.6a
83.2a
0.11
<0.01
<0.01
0.62
3
Marbling Score
569
537
534
543
529
10.6
0.09
<0.01
0.61
Fat depth, cm
1.70
1.65
1.75
1.68
1.63
0.022
0.58
0.70
0.61
4
ab
a
b
a
a
Calculated YG
3.80
3.64
3.90
3.69
3.61
0.077
0.04
0.28
0.78
a,b,c
Means within a row without common superscripts differ (P ≤ 0.05)
1
Implant treatments include: non-implanted negative control (CON), 200 mg TBA + 20 mg estradiol partially coated pellets (Revalor-XH, Merck Animal Health;
XH), 200 mg TBA + 20 mg estradiol uncoated administered on d 1 (Revalor-200, Merck Animal Health; E200), 200 mg TBA + 20 mg estradiol coated implant
(Revalor-XR, Merck Animal Health; XR) and 200 mg TBA + 20 mg estradiol uncoated administered on d 70 (Revalor-200, Merck Animal Health; D200).
2
Common dressing percentage (63%) used to calculate carcass adjusted performance
3
USDA Marbling Scores. 400 = small, 500 = modest, 600 = moderate
4
Yield grade calculated using the following equation: 2.5 + (0.98425 x 12th rib fat, cm) + (0.2 x 3.0 [KPH, %]) + (0.00837 x HCW, kg) – (0.0496 x LM area, cm2)

0.99
0.69
0.90
0.47
0.55
0.13
0.84
0.21
0.92
0.43
0.62
0.38
0.44
0.47
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Table 2.2. Change in quality grade and yield grade distribution of implanted and nonimplanted heifers fed for an average of 198 d (Exp.1)
Implant Treatment1

Quality Grade, %
Prime
Upper Choice
Low Choice
Select
Standard
Yield Grade, %
1
2
3
4
5

CONa, xy

XHb, x

E200b, y

XRab, xy

D200b, x

14.3
56.1
22.3
7.2
0.0

6.2
55.7
26.8
10.3
1.0

4.2
55.4
33.2
7.1
0.0

9
54.0
28.9
8.1
0.0

6.1
49.0
35.9
9.0
0.0

PValue
0.10

0.07
1.0
16.7
48.6
28.6
5.2

2.0
16.7
42.9
34.3
3.0

0.0
11.6
37.8
42.3
8.3

2.0
12.3
48.4
34.2
3.0

1.0
16.4
45.1
36.4
1.0

Implant treatments include: non-implanted negative control (CON), 200 mg TBA + 20 mg
estradiol partially coated pellets (Revalor-XH, Merck Animal Health; XH), 200 mg TBA + 20 mg
estradiol uncoated administered on d 1 (Revalor-200, Merck Animal Health; E200), 200 mg TBA +
20 mg estradiol coated implant (Revalor-XR, Merck Animal Health; XR) and 200 mg TBA + 20
mg estradiol uncoated administered on d 70 (Revalor-200, Merck Animal Health; D200).
a, b
Means within row without common superscript differ (P ≤ 0.05) for quality grade distribution
x, y
Means within row without common superscript differ (P ≤ 0.05) for yield grade distribution
1

Table 2.3. Interim growth performance of implanted and non-implanted heifers fed for an average of 198 d (Exp. 1)
Implant Treatments1

CON

XH

E200

XR

D200

F-Test

P-Value
CON
vs
XR vs
Implant
D200

XH vs
D200

Day 0-70
Initial BW, kg
281
281
280
280
280
1.000
0.94
0.99
0.95
Day 35 BW, kg
322
327
332
321
322
0.21
0.43
0.83
0.33
Day 70 BW, kg
370
379
384
370
370
0.09
0.23
0.96
0.19
DMI, kg/d
8.8
8.9
8.9
8.6
8.9
0.34
0.55
0.16
0.68
ADG, kg/d
1.29a
1.42b
1.50c
1.30a
1.31a
<0.01
0.01
0.89
0.01
G:F
0.148a
0.159b
0.169c
0.151a
0.147a
<0.01
<0.01
0.28
<0.01
Day 70-140
Day 105 BW, kg
426
440
443
436
433
0.13
0.03
0.65
0.30
Day 140 BW, kg
472a
494b
493b
492b
491b
0.02
<0.01
0.94
0.71
DMI, kg/d
9.8
10.4
10.3
9.9
10.0
0.07
0.06
0.77
0.09
ADG, kg/d
1.46d
1.65bc
1.57c
1.74a
1.73ab
<0.01
<0.01
0.83
0.08
G:F
0.149c
0.160b
0.153bc
0.176a
0.173a
<0.01
<0.01
0.54
<0.01
Day 140-End
Day 175 BW, kg
522a
546b
543b
546b
542b
<0.01
<0.01
0.54
0.56
Final BW, kg
563
580
577
580
577
0.32
0.04
0.70
0.80
DMI, kg/d
10.6
11.0
10.7
10.8
10.9
0.18
0.06
0.76
0.47
ADG, kg/d
1.57
1.48
1.43
1.51
1.47
0.23
0.05
0.46
0.82
G:F
0.149a
0.134b
0.134b
0.140ab
0.134b
0.04
<0.01
0.37
0.93
a, b, c
Means with a row without common superscripts differ (P ≤ 0.05)
1 Implant treatments include: non-implanted negative control (CON), 200 mg TBA + 20 mg estradiol partially coated pellets (Revalor-XH, Merck Animal Health;
XH), 200 mg TBA + 20 mg estradiol uncoated administered on d 1 (Revalor-200, Merck Animal Health; E200), 200 mg TBA + 20 mg estradiol coated implant
(Revalor-XR, Merck Animal Health; XR) and 200 mg TBA + 20 mg estradiol uncoated administered on d 70 (Revalor-200, Merck Animal Health; D200).
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Table 2.4. Blood sera metabolite concentrations in 35-d increments in implanted or non-implanted heifers fed for an average of 198 d (Exp. 1)
Treatment1

Blood Urea-N, mg/dL
d 12
d 35
d 70
d 105
d 140
d 175
NEFA, mEq/L
d 12
d 35
d 70
d 105
d 140
d 175
IGF-1, ng/mL
d 12
d 35
d 70
d 105
d 140
d 175
17β-TbOH pg/mL3
d 12
d 35
d 70
d 105
d 140
d 175

P-Value

CON

XH

E200

XR

D200

15.2
13.5
16.0
17.4
16.8
18.6

16.0
12.9
15.9
17.8
17.0
19.1

15.9
13.1
15.6
18.1
17.4
19.8

16.2
13.6
15.7
17.7
16.8
20.2

16.4
14.3
16.8
16.3
16.4
18.3

323.5
177.2
180.1
160.8
191.6
142.4

340.4
173.8
178.2
167.1
166.8
179.0

311.7
186.1
208.2
174.8
171.1
174.0

326.8
162.3
195.6
172.8
184.1
164.1

348.2
172.7
166.8
172.8
189.8
171.7

52.2
56.8
73.9
70.7
72.5
82.4

52.6
71.1
100.6
96.5
95.5
100.1

53.9
67.4
82.1
87.8
90.6
94.7

49.2
68.2
85.9
88.0
84.6
86.2

46.8
66.0
84.1
90.3
88.3
94.5

ND3
NDb
NDc
NDc
NDc
NDb

ND
53.8b
45.9bc
55.8bc
39.9bc
NDb

ND
121.2a
116.5a
57.1bc
24.0bc
21.6b

ND
23.2b
72.6ab
147.2a
102.2a
48.0ab

ND
NDb
NDc
103.8ab
63.4ab
80.1a

SEM
0.82

Time x
Treatment
0.72

Treatment
0.87

Time
< 0.01

Lin.
0.75

Quad.
0.79

14.4

0.59

0.87

< 0.01

0.72

0.50

7.7

0.99

0.12

< 0.01

0.06

0.05

11.7

< 0.01

< 0.01

< 0.01

<0.01

0.37

Means within rows without common superscripts differ (P ≤ 0.05)
Implant treatments include: non-implanted negative control (CON), 200 mg TBA + 20 mg estradiol partially coated pellets (Revalor-XH, Merck Animal Health; XH), 200 mg
TBA + 20 mg estradiol uncoated administered on d 1 (Revalor-200, Merck Animal Health; E200), 200 mg TBA + 20 mg estradiol coated implant (Revalor-XR, Merck Animal
Health; XR) and 200 mg TBA + 20 mg estradiol uncoated administered on d 70 (Revalor-200, Merck Animal Health; D200).
2
Days from initiation of trial
3
ND = Not detectable (12.5 pg/mL)
a, b, c
1
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Figure 2. 1 Effects of implant treatment on circulating sera metabolites (Exp. 1).
a.

Blood Urea-N Concentration

Time P = < 0.01
Trt P = 0.87
Time × Trt P = 0.72

b.
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Figure Description: Effect of implant treatment on sera metabolite concentrations in
finishing heifers. Treatments included: No implant (CON), Revalor-XH (200 mg TBA +
20 mg E2, Merck Animal Health, De Soto, KS; partially coated; XH), Revalor-200 on d 1
(200 mg TBA + 20 mg E2, Merck Animal Health; uncoated; E200), Revalor-XR (200 mg
TBA + 20 mg E2, Merck Animal Health; coated; XR) and Revalor-200 on d 70 (D200).
Baseline measurements for 17β-TbOH were less than the lowest detectable level, which
is 12.5 pg/mL.

Table 2.5 Performance and carcass characteristics for heifers implanted with no implant, Revalor-200 on d 1 and re-implanted with Revalor-200 on d
100, or Revalor XH on d 1 (Exp.2)
Treatments1
NON
575

200/200
597

XH
595

SEM
2.8

CON vs
Implanted
<0.01

Carcass Adjusted Final, kg3, 6

577

598

596

3.0

< 0.01

0.58

DMI, kg/d

11.6

11.7

11.8

0.1

0.12

0.15

Live ADG, kg6

1.71

1.84

1.83

0.016

0.04

0.68

Carcass Adjusted ADG, kg3, 6

1.72

1.85

1.83

0.02

< 0.01

0.55

Live G:F6

0.147

0.158

0.154

0.0013

< 0.01

0.05

Carcass Adjusted G:F3, 6

0.148

0.158

0.155

0.001

<0.01

0.07

HCW, kg 6

364

377

375

2

< 0.01

0.59

Dress, %

63.2

63.2

63.4

0.002

0.74

0.48

LM area, cm2

78.1

80

78.7

1.9

0.63

0.67

12th rib backfat thickness, cm

1.85

1.91

1.91

0.01

0.10

0.94

Marbling score4
Calculated YG5

567
3.98

533
4.07

549
4.11

7
0.11

< 0.01
0.44

0.10
0.79

Item
Final Pen BW, kg2, 6

200/200
vs XH
0.98

1 Treatments

include: No implant (CON), 200 mg TBA + 20 mg E2 (Revalor-200, Merck Animal Health) on d 1 and re-implanted with Revalor-200 on d 100 (200/200), or 200 mg TBA + 20 mg E2
(Revalor-XH, partially coated; Merck Animal Health) (XH)
2 Final Pen BW pencil shrunk 4%
3 Carcass-adjusted performance calculated by HCW divided by a common dressing percent of 63%.
4 400 = small, 500 = modest, 600 = moderate
5 Yield grade calculated using the following equation: 2.5 + (0.98425 x 12 th rib fat, cm) + (0.2 x 3.0 [KPH, %]) + (0.00837 x HCW, kg) – (0.0496 x LM area, cm2)
6 Initial BW was used as a covariate in the model
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Table 2.6. Growth performance and carcass characteristics of heifers fed for 151, 165, 179 or 193 days on feed (Exp. 2)
Treatments1
Item,

Contrasts

NORMAL

PLUS14

PLUS28

PLUS42

SEM

F-Test

Linear

Quadratic

Final Pen BW, kg2, 6

567

579

597

613

3.3

< 0.01

< 0.01

0.46

Carcass Adjusted Final, kg3, 6

558

577

606

623

4.0

< 0.01

< 0.01

0.78

DMI, kg/d

11.7

11.7

11.8

11.8

0.10

0.72

0.38

0.84

Live ADG, kg6

1.89

1.81

1.76

1.72

0.02

< 0.01

< 0.01

0.20

Carcass Adjusted ADG, kg3, 6

1.83

1.79

1.81

1.77

0.02

0.18

0.10

0.99

Live G:F6

0.161

0.155

0.15

0.146

0.0021

< 0.01

< 0.01

0.25

Carcass Adjusted G:F3, 6

0.156

0.154

0.154

0.151

0.002

0.1

0.02

0.84

HCW, kg6

351

363

382

392

2.0

< 0.01

< 0.01

0.79

Dress, %

62.3

62.8

63.9

64

0.002

0.49

0.13

0.63

LM area, cm2

77.4

76.1

82.6

80.6

2.6

0.17

0.09

0.99

12th rib backfat thickness, cm

1.75

1.75

1.96

2.08

0.03

< 0.01

< 0.01

0.09

Marbling score4

538

521

565

574

8

< 0.01

< 0.01

0.11

Calculated YG5
3.83
4
4.04
4.34
0.13
0.05
< 0.01
0.60
1
Treatments include: 151 (NORMAL), 165 (PLUS14), 179 (PLUS28), or 193 (PLUS42) days on feed.
2
Final Pen BW pencil shrunk 4%
3
Carcass-adjusted performance calculated by HCW divided by a common dressing percent of 63%.
4
400 = small, 500 = modest, 600 = moderate
5
Yield grade calculated using the following equation: 2.5 + (0.98425 x 12th rib fat, cm) + (0.2 x 3.0 [KPH, %]) + (0.00837 x HCW, kg) – (0.0496 x
LM area, cm2)
6
Initial BW was included as a covariate in the model
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Figure 2.2. Effect of implant treatment and DOF on backfat thickness of heifers fed
varying DOF (Exp. 2)
A.
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Figure Description: Backfat thickness increased linearly (P < 0.01) as cattle were fed
from 151 to 193 DOF, with no implant treatment × serial harvest interaction (P = 0.26).
There was a tendency for an implant treatment × linear serial harvest interaction (P =
0.12). Treatments included: No implant (CON), Revalor-200 (200 mg TBA + 20 mg E2,
Merck Animal Health, De Soto, KS; uncoated) on d 1 and reimplanted with Revalor-200
on d 100 (200/200), or Revalor-XH (200 mg TBA + 20 mg E2, Merck Animal Health;
partially coated; XH). The equations for effect of implant across DOF were:
y = 0.00781x (± 0.002251) + 0.6459 (± 0.3888) (P < 0.01; CON),
y = 0.01735x (± 0.002251) – 0.8880 (± 0.3888) (P < 0.01; 200/200),
y = 0.01294x (± 0.002251) – 0.1453 (± 0.3888) (P < 0.01; XH).
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CHAPTER III. Evaluation of day of administration of 200 mg TBA and 20 mg
estradiol steroidal implant on heifer and steer performance and carcass
characteristics
C. A. Ohnoutka*, B. M. Boyd*, F. H. Hilscher*, B. L. Nuttelman†, G. I. Crawford†, M.
E. Corrigan†, B. E. Depenbusch⁑ and G. E. Erickson*

*Department of Animal Science, University of Nebraska, Lincoln 68583; †Merck Animal
Health, DeSoto, KS 66018; ⁑Innovative Livestock Services, Inc., Great Bend, KS 67530
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Abstract
Two experiments evaluated the optimal time of administration of a terminal
combination implant following a mild combination implant on finishing heifer and steer
performance. In Exp. 1, crossbred heifers (n = 1,867; initial BW = 268; SD = 9 kg) were
utilized in a 181-d finishing study to evaluate the effects of 4 different days on terminal
(DOT) implant (160, 120, 80 and 40 DOT) on growth performance and carcass
characteristics. Heifers were given an initial implant of 80 mg trenbolone acetate (TBA)
+ 8 mg estradiol (Revalor-IH, Merck Animal Health, De Soto, KS) on d 1. Terminal
implant included 200 mg TBA + 20 mg estradiol (Revalor-200, Merck Animal Health).
No difference was observed in DMI (P ≥ 0.12), but a quadratic response (P ≤ 0.04) was
observed for final BW, ADG and G:F, and were greatest for cattle fed 80 DOT when
carcass-adjusted performance was evaluated. Hot carcass weight was greatest at 80 DOT
(P = 0.03; quadratic). However, LM area and dressing percentage were greatest at 120
DOT (P ≤ 0.10; quadratic). Solving for first derivative, each variable was optimized
between 88 and 103 DOT, with an average of 94 DOT. Interestingly, there was less than
1% difference in ADG and G:F when implanted 21 days either side of optimal DOT. In
Exp. 2, crossbred steers (n = 800; initial BW = 330; SD = 25 kg) were utilized in a 180-d
finishing study to evaluate 160, 120, 100, 80 or 40 DOT on growth performance and
carcass characteristics. All steers were given an initial implant (80 mg TBA + 16 mg
estradiol; Revalor-IS, Merck Animal Health) on d 1 followed by a terminal implant
(Revalor-200, Merck Animal Health). DMI was the lowest for 40 DOT (P ≤ 0.04), with
no differences between other treatments (P ≥ 0.11). Carcass-adjusted final BW, ADG,
and G:F responded quadratically (P ≤ 0.05), with 80 to 120 DOT being the greatest, with
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less than 2% difference over the 40 d period. Hot carcass weight increased quadratically
(P = 0.03), LM area increased linearly (P < 0.01), and there were no differences in fat
thickness, marbling score, or calculated yield grade (P ≥ 0.27) as DOT increased. When
solved for the first derivative, final BW, ADG, G:F, and HCW were optimized between
87 and 104 DOT. The optimal DOT appears to be between 80 and 120 DOT, with an
average of 96 DOT for both steers and heifers. These data show flexibility in reimplant
windows, allowing feedlot personnel flexibility in making management decisions to best
suit their labor, weather and marketing constraints.
Keywords: Implants, Payout, Reimplanting
Introduction
Anabolic implants are a proven management tool that have been shown to
increase performance and efficiency in feedlot cattle for more than 50 years (Hickman et
al., 1994; Nichols et al., 2002). Since the approval of implants in 1954, many
combinations of dosage and ratios of steroid hormones have been approved for use in
cattle (Nichols et al., 2002). However, many implants only last 60 to 120 d until no
longer effective. Many times, cattle require more than 120 days on feed, which then
creates the need for two or more implants during the finishing phase to optimize
performance. When steers were implanted with a combination (trenbolone acetate +
estradiol) implant as an initial implant and reimplanted with a combination implant, ADG
was improved by 20% and feed efficiency was improved by 13.5% compared to nonimplanted steers (Duckett and Pratt, 2014). However, with an increased demand for
improved gains and efficiency, while also feeding cattle longer days on feed, there are
limited data on the optimal time to administer a terminal implant. Therefore, the objective
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of these experiments was to identify the optimal time for administering a terminal
combination implant following a mild combination initial implant in heifers or steers fed
for approximately 180 d.
Materials and Methods
All procedures used in these experiments were reviewed and approved by the
University of Nebraska- Lincoln Institutional Animal Care and Use Committee (IACUC).
Experimental Design and Procedures
Experiment 1
A study was conducted at a commercial feedlot (Barton County Feeders) near
Ellinwood, KS. Crossbred heifers (n = 1,867; initial BW= 268; SD = 9 kg) were utilized
in a randomized complete block design with six blocks consisting of 4 adjacent pens per
block. Heifers were received from 10 sale barns in Kansas (n = 9) and Nebraska (n = 1).
On arrival, heifers were allowed ad libitum access to fresh water and long-stemmed hay.
Cattle were randomly allotted to 4 different sort pens (5 animals at a time) until the
desired head count was achieved in each pen or until there were no more animals in the
respective purchase group. In this case, the next purchase group was continued sorting
into the 4 different pens 5 animals at a time. This allotment procedure was repeated until
all pens were filled to a similar bunk space and pen space per animal. Treatments were
assigned randomly to pens within block and consisted of 4 different days on terminal
(DOT) implant (160, 120, 80 and 40 d).
Heifers were received at a commercial feedyard over the course of approximately
3 weeks and during this time had ad libitum access to water and long-stemmed hay.
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Heifers were processed according to the standard operating procedures of the facility.
Heifers were identified with color-coordinated and numbered tags in each ear. The right
ear tag contained the lot number and the left ear tag contained the lot number and the
individual animal ID number. Heifers were vaccinated for infectious bovine
rhinotracheitis (IBR), bovine viral diarrhea virus (BVDV) (types 1 and 2), parainfluenza3
(PI3), bovine respiratory syncytial virus (BRSV), Mannheimia haemolytica, and
Pasteurella multocida (Vista Once, Merck Animal Health, DeSoto, KS). In addition,
heifers received an injection of one percent doramectin for treatment and prevention of
gastrointestinal and external parasites (Dectomax; Zoetis Animal Health, Florham Park,
NJ), oral drench of fenbendazole for removal and prevention of worms (Safeguard;
Merck Animal Health), topical application of one percent lambda-cyhalothrin for the
control of lice and horn flies (Exile, Aspen Veterinary Resources, Liberty, MO) pour onto
the back, metaphylaxis injection of an antibiotic for the control of respiratory infection
caused by Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni
(Zuprevo, Merck Animal Health), and a growth implant (80 mg of trenbolone acetate + 8
mg of estradiol, Revlor-IH Merck Animal Health) under the skin of the posterior, middle
third of the ear. Approximately 15 to 20 days after processing heifers were revaccinated
for IBR, BVDV types 1 and 2, PI3, and BRSV (Vista 5 SQ, Merck Animal Health).
Heifers received their terminal implant (Revalor-200; 200 mg of trenbolone
acetate + 20 mg of estradiol, Merck Animal Health) at 160, 120, 80, and 40 days prior to
predetermined harvest dates based on assigned treatment. In addition, heifers were
revaccinated (Vista 5 SQ, Merck Animal Health) at reimplant.
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Heifers were housed in 24 dirt-surfaced pens providing 33.3 linear cm of bunk
space and 22 m2 of pen space per heifer. Diets were fed three times daily at
approximately 0700, 1000, and 1350 h. Trained personnel evaluated heifers for overall
wellbeing daily. Pens within a block were treated the same as it pertains to transitioning
onto the finishing ration. Heifers were fed a starter ration, which included 29% steamflaked corn, 22.2% WDGS, 38% alfalfa hay, 7% corn silage, and 3.8% supplement (DM
basis), for 4 to 6 days. Alfalfa hay and corn silage were replaced with steam-flaked corn
as steps progressed. Heifers were fed half of their diet as the starter ration and half as
ration 2 for 2 to 4 days before being fed ration 2 alone for 5 to 6 days. Heifers were then
transitioned to ration 3 using a 50:50 blend of ration 2 and ration 3 before being fed
ration 3 alone for 5 to 6 days. Finally, heifers were transitioned to the finishing ration
using a 3 to 4-day split feeding of both rations 3 and the finisher. The finisher ration
included 66.6% steam-flaked corn, 18% WDGS, 4.3% mixed hay, 3.2% corn silage,
2.9% tallow, and 5% supplement. Supplement was formulated to provide 300 mg
monensin (Rumensin, Elanco Animal Health, Greenfield, IN), 90 mg of tylosin (Tylan,
Elanco Animal Health), 0.5 mg of melengestrol acetate (MGA, Zoetis Animal Health),
and 50 g Bovamine Defend (Nutrition Physiology Company, Overland Park, KS) per
heifer daily and 250 mg of ractopamine hydrochloride (Actogain, Zoetis Animal Health)
per heifer daily during the last 28 DOF.
Heifers were on trial for approximately 181 d prior to harvest. On the morning of
shipping prior to feeding, heifers were weighed by pen on a large platform scale. Heifers
were then transported to a commercial abattoir located in Holcomb, KS. Heifers were
processed on May 24th, 2016 (1 block), June 2nd, 2016 (1 block), June 7th, 2016 (2
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blocks), and June 14th, 2016 (2 blocks). Heifers were kept with their pen mates during
the shipping and harvest process. Trained personnel at the abattoir collected carcass
measurements using camera grading system. Carcass weight, liver score, USDA quality
grade, USDA yield grade, kidney, pelvic, and heart fat, 12th rib fat thickness, LM area,
and marbling score were collected for each animal at the abattoir. Average dressing
percentage was calculated using the total carcass weight and shrunk (4%) final weight of
the entire pen. Calculated yield grade was calculated using the following: 2.5 + (0.98425 x
12th rib fat, cm) + (0.2 x 3.0 [KPH, %]) + (0.00837 x HCW, kg) – (0.0496 x LM area, cm2).
Statistical Analysis Exp. 1
Growth performance and carcass characteristics were analyzed using the MIXED
procedure of SAS (9.3, SAS Institute, Cary, NC). Pen was the experimental unit and
block was included as a random effect. Linear and quadratic contrasts of DOT were used
to compare treatment differences. Treatment averages were calculated using the
LSMEANS option of SAS. Quality and yield grade distributions were analyzed using the
GLIMMIX procedure of SAS using a multinomial approach. Data were considered
significant at P ≤ 0.05 and a tendency at 0.05 < P ≤ 0.10.
Experiment 2
A feedlot study was conducted at the University of Nebraska Eastern Nebraska
Research and Extension Center (ENREC) near Mead, NE. Crossbred yearling steers (n =
800; initial BW = 330; SD = 25 kg), were utilized in a generalized randomized block
design with two initiation times and three BW blocks within initiation time. Steers were
sourced from auction markets and transported to the research site. At the time of feedlot
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arrival, all steers were individually identified (panel tag, electronic ear button, and metal
clip). Steers received an infectious bovine rhinotracheitis (IBR) virus, parainfluenza-3
(PI3) virus, bovine viral diarrhea (BVD) virus (types I and II), bovine respiratory
syncytial virus (BRSV), Mannheimia haemolytica and Pasteurella multocida
combination vaccine (Vista Once, Merck Animal Health), a Clostridium chauvoei,
specticum, novyi, sordellii, perfringens Types B, C, and D bacterin-toxoid (Vision 7,
Merck Animal Health), a 10 percent fenbendazole oral suspension for the control of lung
worms, stomach worms, and intestinal worms (Safe-Guard Dewormer, Merck Animal
Health), and one percent doramectin injectable for treatment and prevention of
gastrointestinal and external parasite control (Dectomax, Zoetis Inc.). Five d prior to trial
initiation, steers were limit fed a common diet of 50% Sweet Bran (Cargill Corn Milling,
Blair, NE) and 50% alfalfa hay at 2% of BW and weighed for 2 consecutive d (d 0 and 1)
to establish initial BW and to limit differences in BW due to gastrointestinal fill (Watson
et al., 2013). Using d 0 weights, steers were blocked by BW (n=3), stratified within
block, and assigned randomly to pens (n=40). Pens were assigned randomly to one of
five treatments with 20 steers per pen and 8 pens / treatment.
All steers were implanted with 80 mg TBA and 16 mg E2 on d 1 (Revalor-IS,
Merck Animal Health). Treatments consisted of varying days on terminal implant (160,
120, 100, 80, 40 d). Terminal implant included 200 mg of TBA and 20 mg of E2
(Revalor-200, Merck Animal Health). All cattle were implanted under the skin of the
posterior, middle third of the ear.
Steers were adapted to a common finishing diet over a 24-d period consisting of
four adaptation diets. The amount of wet distiller’s grains (WDGS), Sweet Bran, grass
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hay and supplement were held constant at 15%, 25%, 6% and 4% (DM basis) of the diet
DM, respectively. The amount of dry rolled corn (DRC) was gradually increased while
replacing alfalfa. The first adaptation diet consisted of 12.5% DRC and 37.5% alfalfa hay
and was fed for 5 d. The second adaptation diet was fed for 5 d and consisted of 22.5%
DRC and 27.5% alfalfa hay. The third adaptation diet included 32.5% DRC and 17.5%
alfalfa hay and was fed for 7 d. The fourth and final adaptation diet included 42.5% DRC
and 7.5% alfalfa hay and was fed for 7 d. The finishing diet included 50% DRC, 15%
WDGS, 25% Sweet Bran, 6% grass hay and 4% supplement, all on DM basis. The
supplement was formulated to provide 30 g/ton of monensin (Rumensin, Elanco Animal
Health) and 8.9 g/ton DM tylosin (Elanco Animal Health).
Steers were housed in open feedlot pens with approximately 45.5 cm of linear
bunk space and 28 m2 of pen space per head. Feed bunks were assessed once daily at
approximately 0600 for presence of feed. Feed amounts were increased or decreased
daily to maintain an ad libitum bunk management approach. Cattle were fed once daily
between 0700 and 0900 and had ad libitum access to fresh water and feed. Diets were
mixed and delivered using a truck-mounted feed mixer and delivery unit (Roto-Mix
model 420, Roto-Mix, Dodge City, KS). When refusals were present, orts were weighed,
sampled and frozen for later analysis of DM. Dry matter of orts were determined by
placing samples in a 60° C forced-air oven for 48 h (AOAC Method 935.29; AOAC,
1999). Cattle were visually evaluated daily by trained UNL personnel. Evaluations
include proper functionality of water tanks, integrity of fences and feed bunks, and any
abnormal behavior of the cattle. When steers were determined to be sick, steers were
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removed from the pen and taken to the processing facility for diagnosis and appropriate
treatment.
On day of shipping, steers were offered 50% of the previous day’s called feed. In
the afternoon, all steers were brought to the handling facility, pen weighed to determine
final live BW, and loaded onto trucks. All animals were harvested at a commercial
harvest facility (Greater Omaha, Omaha, NE) after 180 d on feed. Carcass data collection
was performed by UNL personnel. Hot carcass weight and liver scores were recorded on
day of harvest. After a 48-h chill, LM area, 12th rib fat thickness, and USDA marbling
score were recorded using camera grading. Yield grade was calculated (USDA, 2016)
from the following formula: 2.5 + (0.98425 x 12th rib fat, cm) + (0.2 x 3.0 [KPH, %]) +
(0.00837 x HCW, kg) – (0.0496 x LM area, cm2). Live final BW was pencil shrunk 4% to
calculate dressing percentage and live performance. A common dressing percentage of
63% was used to calculate carcass adjusted final BW, ADG, and G:F.
Statistical Analysis Exp. 2
Growth performance and carcass data were analyzed using the MIXED procedure
of SAS 9.4 (SAS Institute, Cary, NC). Pen was the experimental unit and BW block,
initiation block and BW block nestled within initiation block were included as fixed
effects. Linear and quadratic DOT contrasts were used to compare treatment differences.
Quality and yield grade distributions were analyzed using the GLIMMIX procedure of
SAS using a multinomial approach. Data were considered significant at P ≤ 0.05 and a
tendency at 0.05 < P ≤ 0.10.
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Results and Discussion
Exp. 1
There were no differences in initial BW between treatment groups (P ≥ 0.18;
Table 3.1). Dry-matter intake was the same for all treatments (P ≥ 0.12). Using carcassadjusted performance, there was a quadratic response to final BW (P = 0.04) and ADG (P
= 0.01) with 80 DOT having the greatest ending BW and gain, and in turn, being the
most efficient (P = 0.01; quadratic).
Figure 3.1 illustrates the quadratic response and the respective regression
equations of each variable. Each of these variables were optimized between 88 and 103
DOT with an average optimal DOT of 94 (87 d on initial implant) when heifers are fed
for 181 d. However, growth performance was only reduced by 1% when calculated at 21
days on either side of the first derivative. These results suggest that the feedyard operator
has a 40 d window to move the scheduled terminal implant date around with minimal
effects of growth performance.
Interim growth performance data are summarized in Table 3.2. Interestingly,
ADG was different between days 0 and 21 (P = 0.02). These differences were not
expected and are not due to any treatment effect since the experimental treatment had not
been applied at this point. As expected, ADG and G:F were greater (P ≤ 0.05) in each
period following the day when the terminal implant treatment was applied. The only
exception was ADG in the last period when the 40 DOT treatment was applied, in which
ADG was similar (P ≥ 0.05) between the 80 and 40 DOT treatments. This may suggest
that the terminal implant was not fully utilized and had not completely released all the
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hormones in the last 40 d period. The heifers that received the shortest DOT (i.e., 40)
treatment also had the longest days on initial implant (i.e., 141 days). Therefore, the
ADG response in the 40 DOT treatment may also be due to the terminal implant and less
response from the initial implant due to length of implant window.
Carcass characteristics are summarized in Table 3.3. Hot carcass weight and LM
area responded quadratically (P ≤ 0.03) to DOT, with the greatest HCW response at 80
DOT and the greatest LM area at 120 DOT. Dressing percentage tended to respond
quadratically (P = 0.06), with 120 DOT having the greatest dressing percent.
Interestingly, USDA marbling score increased linearly (P = 0.03) as DOT decreased.
Bruns et al (2005) observed that cattle implanted with greater doses of TBA + estradiol
early in the feeding period had in decreased marbling scores, which agrees with our
observations as marbling score was affected the greatest when cattle received both the
initial and terminal implant within the first 20 DOF (160 DOT). Contrary to these results,
Duckett (2004) concluded that reimplanting with a combination implant half way through
the feeding period resulted in lower marbling scores, therefore contributing the effects on
marbling to timing of terminal implant administration compared to cattle given only an
initial implant. Quality grade (P < 0.01) and yield grade (P < 0.01) distributions were
both altered by days on terminal implant (Table 3.4). Calculated yield grade did not
change across treatments (P ≥ 0.25), which does not agree with observations by Duckett
et al. (1997), who observed decreased yield grades due to decreased fat thickness in
heifers given two implants.
Experiment 2
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Dry matter intake was the least for 40 DOT (P ≤ 0.04, Table 3.6), with no
differences between the other treatments (P ≥ 0.11). This agrees with Milton et al. (2000)
who found that steers either delay implanted or implanted with a combination implant
and reimplanted with a combination implant 82 d prior to harvest had the greatest DMI
compared to cattle given a less aggressive dose or only implanted on d 1. Carcassadjusted final BW responded quadratically (P = 0.03) with 100 DOT having the greatest
final BW, but 100 DOT was not different from 120 DOT (P = 0.82). Carcass-adjusted
ADG responded quadratically (P = 0.02), with 100 and 120 DOT being the greatest, but
not different (P = 0.87) and 80 DOT being intermediate (P ≥ 0.57). There was less than
1% difference in carcass-adjusted ADG between 80, 100 or 120 DOT. When solved for
the first derivative, ADG was maximized at 99 DOT. Carcass-adjusted G:F also
responded quadratically (P < 0.01), with 160 DOT being the least efficient, but no
differences between other treatments (P ≥ 0.13). Compared to 120 DOT, there was a
1.6% increase in G:F when cattle were reimplanted 100 days prior to harvest and a 0.5%
increase in G:F for 100 DOT compared to 80 DOT. There was a 1.2% improvement in
G:F when steers were reimplanted 80 d prior to slaughter compared to 120 DOT. When
solved for the first derivative, G:F was maximized at 87 DOT. These results disagree
with Rumsey et al. (1992), where steers implanted 60, 90, or 120 d prior to harvest had
similar ADG and feed efficiencies regardless of implant protocol. Johnson et al. (2013)
concluded to gain optimal benefit from an implant, it is vital to utilize the implant until
most of the hormone has been paid out.
Interim data are presented in Table 3.7. As expected, ADG and G:F were greater
in most cases in each period following the day in which the terminal implant was applied.
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The exception to this was when the 120 DOT treatment was applied. There were no
statistical differences in ADG or G:F between treatments (P ≥ 0.16), but the 120 DOT
treatment was not numerically greater compared to the other treatments. There was a
tendency (P = 0.06) for ADG to be different among treatments during d 82 to 101,
however, the applied treatment (100 DOT) was not the greatest. Because DMI was the
lowest for 100 DOT during that period (P < 0.01), 100 DOT did have had the greatest
G:F during that period (P = 0.02).
Carcass characteristics are summarized in Table 3.8. Hot carcass weight
responded quadratically (P = 0.03), with the greatest at 100 DOT. When solved for the
first derivative, HCW was maximized at 104 DOT. There were no differences in BF
thickness (P = 0.81). The lack of differences in subcutaneous fat thickness is consistent
with most research trials that compare various implant schemes (Duckett, 2004). There
was a linear increase in LM area as DOT increased, with 100 and 120 DOT having the
greatest LM area (P ≤ 0.05). Al-Maamari et al. (1995) found when steers received an
initial combination implant and were reimplanted on d 61 (87 DOT), reimplanted cattle
had greater amount of salable lean without increasing the amount of fat trim. There were
no statistical differences in USDA marbling scores (P = 0.27), however, 100 DOT
numerically had the greatest marbling score. Several other studies show a decrease in
marbling score with more aggressive implant strategies (Bartle et al., 1992; Platter et al.,
2003; Smith et al., 2007) which may be observed with steers with longer DOT, not giving
the initial implant enough opportunity to payout. Samber et al. (1996) reported that a
decrease in intramuscular fat is expected when combination TBA + estradiol implants are
administered more than once or late in the finishing phase, however that was not
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observed in this study. In a historical review of the use of implants by Montgomery et al.
(2001), the authors reported that delayed implanting or using a mild combination implant
initially prevents negative effects on marbling score because it is thought that
intramuscular fat deposition happens early in the feeding period. This idea would support
100 DOT having the greatest numerical marbling score without sacrificing other carcass
merits. There were no statistical differences observed in calculated yield grade (P = 0.38).
Likewise, there were no differences in quality and yield grade distribution for DOT (P =
0.56 and 0.84, respectively; data not shown). Milton et al. (2000) also observed no
differences for marbling score or the percent of steers grading Choice or better when
comparing delayed implanting or mild initial implant followed by reimplanting with a
combination implant.
Overall, administering an initial implant at the beginning of the finishing phase
followed by a terminal implant on average 96 d prior to slaughter increased growth
performance and carcass characteristics in heifers and steers when fed for approximately
180 d compared to administering a terminal implant earlier or later in the finishing
period. However, with minimal changes in performance and carcass characteristics across
treatments when cattle were reimplanted 80 to 120 d prior to harvest suggests feedlot
personnel have flexibility in timing of implants with minor impact on performance.
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Table 3.1 Effect of days on terminal implant on growth performance of heifers fed for 181 d (Exp.1)

Item
Heifers (pens), n

160
(6) 467

Days on Terminal Implant1
120
80
(6) 467

(6) 466

40
(6) 467

SEM
-

Linear
-

P-Value
Quadratic
-

Live Performance
Initial BW, kg2
257
257
257
258
3.3
0.18
Final BW, kg2
544
548
550
547
4.4
0.44
DMI, kg
8.9
8.7
8.7
8.7
0.11
0.12
ADG, kg
1.59
1.61
1.62
1.59
0.02
0.69
G:F
0.179
0.185
0.186
0.183
0.065
0.16
Carcass-adjusted performance
Initial BW, kg2
257
257
257
258
3.3
0.18
3
Final BW, kg
540
545
548
540
4.3
0.33
ADG, kg
1.56
1.59
1.60
1.57
0.02
0.63
G:F
0.176
0.183
0.184
0.180
0.065
0.10
1
Days on terminal implant (Revalor-200; Merck Animal Health) after initial implant (Revalor-IH; Merck Animal Health)
2
Initial and final BW pencil shrunk 4%
3
Carcass-adjusted final BW calculated by dividing HCW by common dressing percent of 63.75%

0.85
0.25
0.17
0.07
0.02
0.85
0.04
0.01
0.01
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Table 3.2 Effect of days on terminal implant on interim growth performance of
heifers fed for 181 d (Exp 1)
Days on Terminal Implant1
Item

160

120

80

40

SEM

F-Test

Lin.

Quad.

6.5

6.4

6.4

6.4

0.19

0.37

0.67

0.73

ADG, kg/d

2.08a

1.97bc

1.92c

2.06ab

0.09

0.02

0.76

0.16

G:F

0.313

0.303

0.293

0.318

0.221

0.08

0.93

0.41

8.3

8.2

8.1

8.2

0.10

0.41

0.46

0.24

ADG, kg/d

1.65a

1.49b

1.51b

1.50b

0.04

0.01

0.02

0.06

G:F

0.198a

0.182b

0.186b

0.182b

0.131

0.01

0.04

0.15

9.2

9.0

9.0

9.2

0.11

0.29

0.96

0.13

ADG, kg/d

1.63a

1.83b

1.64a

1.63a

0.05

0.01

0.37

0.04

G:F

0.177a

0.203b

0.181a

0.177a

0.133

0.01

0.26

<0.01

9.6

9.4

9.4

9.4

0.12

0.16

0.28

0.28

ADG, kg/d

1.35a

1.39a

1.56b

1.31a

0.06

0.01

0.89

0.02

G:F

0.140b

0.147ab

0.165a

0.138c

0.284

0.01

0.58

<0.01

9.5

9.4

9.4

9.2

0.16

0.18

0.26

0.64

ADG, kg/d

1.48a

1.54a

1.61ab

1.70b

0.06

0.02

0.02

0.77

G:F

0.156a

0.164ab

0.169b

0.183c

0.204

0.01

<0.01

0.60

Day 1-20
DMI, kg

Day 21-61
DMI, kg

Day 62-101
DMI, kg

Day 102-141
DMI, kg

Day 142-181
DMI, kg

1

Days on terminal implant (Revalor-200; Merck Animal Health) after initial implant
(Revalor-IH; Merck Animal Health)
abc
Means without a common superscript within a row are different (P ≤ 0.05)

Table 3.3 Effect of days on terminal implant on carcass characteristics of heifers fed for 181 d (Exp. 1)
Days on Terminal Implant1
160

120

P-Value

80

40

SEM

Linear

Quadratic

HCW, kg

344

348

349

346

2.7

0.32

0.03

Dress, %

63.2

63.5

63.4

63.2

0.23

0.96

0.06

KPH fat, %

2.18

2.13

2.15

2.16

0.035

0.45

0.10

12th rib fat
thickness, cm

1.52

1.57

1.57

1.55

0.04

0.70

0.40

LM area, cm2

79.3

81.7

81.0

79.4

0.87

0.85

0.01

Marbling score3

439

441

449

460

9.2

0.03

0.47

Calculated YG4

3.47

3.40

3.45

3.50

0.057

0.50

0.25

1

Days on terminal implant (Revalor-200; Merck Animal Health) after initial implant (Revalor-IH; Merck Animal Health)
400 = small 00; 500 = modest 00; 600 = moderate 00
4
Calculated using the following equation: 2.5 + (0.98425 x 12th rib fat, cm) + (0.2 x 3.0 [KPH, %]) + (0.00837 x HCW, kg) – (0.0496 x LM area,
cm2) (USDA, 2016)
3

100

101

Table 3.4. Effect of days on terminal implant on quality and yield grade distribution for
heifers fed 181 d (Exp.1)
Days on Terminal Implant1
160a, x

120b, x

80a, x

40a, y

Quality Grade, %

< 0.01

Prime

1.8

2.0

2.2

3.9

Choice

76.8

77.2

81.1

77.9

Select

21.2

20.4

16.4

17.8

0.2

0.4

0.2

0.4

No Roll

P-Value

Yield Grade, %

< 0.01

1

4.9

5.4

4.5

3.0

2

22.5

26.0

22.4

23.7

3
47.4
41.7
48.2
43.8
4
22.4
24.3
23.0
26.5
5
2.8
2.6
1.9
3.0
1
Days on terminal implant (Revalor-200; Merck Animal Health) after initial implant
(Revalor-IH; Merck Animal Health)
a, b
Means without common superscripts differ (P ≤ 0.05) for quality grade distribution
x, y
Means without common superscripts differ (P ≤ 0.05) for yield grade distribution

Figure 3.1 Response curves and equations of varying days on terminal implant for heifers fed 181 d (Exp. 1).
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Figure Description: Response to days on terminal implant in heifers that were initially implanted with Revalor-IH (80 mg TBA + 8
mg estradiol; Merck Animal Health) and reimplanted with Revalor-200 (200 mg TBA + 20 mg estradiol) respective to treatment (160,
120, 80, or 40 days on terminal implant). A quadratic response (P ≤ 0.04) was observed for carcass-adjusted final BW, ADG, G:F,
HCW and LM area. When the first-derivative was solved, all variables were optimized between 88 and 103 DOT, with an average of
94 DOT.
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Table 3.5. Quadratic equations for response variables when heifers are fed for 181 d (Exp. 1)
Response Variable

Equation

R2- Quadratic
Value
P-Value

Carcass-Adj. BW

y = -0.00167x2 (±0.001305) – 0.31x (±0.2650) + 532.75 (±11.6212)

0.0847

0.04

Carcass-Adj. ADG

y = -0.00001x2 (±0.0000608) – 0.002065x (±0.001235) + 1.5021 (±0.05414)

0.1295

0.01

Carcass Adj. G:F

y = 0.00000174x2 (±0.00498) – 0.000317x (±0.000133) +0.1700 (±0.005835)

0.3002

0.01

LM Area

y = -0.00063x2 (±0.000268) + 0.1272x (±0.05452) + 75.1992 (±2.3907)

0.2083

0.01

HCW

y = -0.00104x2 (±0.000829) – 0.1942x (±0.1685) + 339.67 (±7.3885)

0.0847

0.03
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Table 3.6. Effect of days on terminal implant on growth performance of steers fed for 180 d (Exp. 2)

Days on Terminal Implant1

P-Values

160

120

100

80

40

SEM

Trt2

Linear

Quad

Initial Weight, kg

330

330

331

331

330

1.4

0.70

0.41

0.96

Final Weight, kg3

657

667

672

667

659

4.8

0.17

0.32

0.05

ADG, kg

1.83

1.89

1.90

1.89

1.83

0.025

0.11

0.42

0.03

DMI, kg/d

11.8

11.9

11.8

11.7

11.4

0.09

0.01

0.18

0.93

G:F

0.155

0.158

0.162

0.161

0.160

0.0018

0.04

0.90

0.01

672

685

686

681

669

4.3

0.03

0.13

0.03

1.91

1.98

1.98

1.97

1.89

0.022

0.01

0.18

0.02

0.161

0.166

0.169

0.168

0.165

0.0014

0.01

0.66

<0.01

Live Performance

Carcass Adjusted Performance
Final Weight, kg4
5

ADG, kg
5

G:F
1

Days on terminal implant (Revalor-200; Merck Animal Health) after initial implant (Revalor-IS; Merck Animal Health)
2
F-test for effect of day on terminal implant
3
Pencil shrunk 4%
4
Carcass-adjusted performance calculated from HCW using a common dressing percentage of 63%
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Table 3.7. Effect of days on terminal implant on interim growth performance of steers fed
for 180 d (Exp 2)
Days on Terminal Implant1
160

120

100

80

40

SEM

F-Test

Lin.

Quad.

DMI, kg/d

9.2

9.4

9.4

9.3

9.2

0.09

0.47

0.16

0.77

ADG, kg

1.54

1.62

1.78

1.54

1.49

0.114

0.48

0.13

0.32

G:F

0.168

0.172

0.189

0.167

0.162

0.0119

0.56

0.16

0.32

DMI, kg/d

11.2

11.4

11.1

11.3

11.0

0.14

0.42

0.99

0.96

ADG, kg

2.39

2.14

2.09

2.22

2.16

0.059

<0.01

0.12

0.09

G:F

0.213

0.188

0.188

0.197

0.195

0.0054

0.01

0.17

0.12

DMI, kg/d

12.6

12.1

12.3

12.4

11.9

0.15

0.04

0.92

0.35

ADG, kg

2.38

2.52

2.31

2.29

2.25

0.095

0.34

0.44

0.36

G:F

0.188

0.208

0.186

0.183

0.189

0.0077

0.16

0.43

0.17

DMI, kg/d

12.3

12.4

11.4

11.8

12.0

0.17

<0.01

0.35

<0.01

ADG, kg

1.67

1.89

1.78

1.58

1.47

0.100

0.06

0.03

0.95

G:F

0.135

0.152

0.155

0.134

0.122

0.0076

0.02

<0.01

0.23

DMI, kg/d

12.6

12.8

12.4

12.1

12.1

0.13

<0.01

0.01

0.12

ADG, kg

1.78

2.01

2.04

1.97

1.79

0.054

<0.01

0.09

<0.01

G:F

0.141

0.158

0.164

0.163

0.149

0.0039

<0.01

0.45

<0.01

DMI, kg/d

12.3

12.7

12.8

12.7

11.8

0.17

<0.01

0.14

<0.01

ADG, kg

1.22

1.23

1.45

1.52

1.65

0.082

<0.01

0.1

0.08

G:F

0.099

0.097

0.114

0.121

0.139

0.0063

<0.01

0.03

0.25

Day 1-20

Day 21-61

Day 62-81

Day 82-101

Day 102-141

Day 142-180

1

Days on terminal implant (Revalor-200; Merck Animal Health) after initial implant (Revalor-IS;
Merck Animal Health). Terminal implants were administered on d 21, 61, 101, 121, and 141.

Table 3.8. Effect of days on terminal implant on carcass characteristics of steers fed for 180 d (Exp 2)
Days on Terminal Implant1

P-Values

160

120

100

80

40

SEM

Treatment

Linear

Quad

HCW, kg

424

431

432

429

422

2.7

0.03

0.14

0.03

LM area, cm2

88.4

90.3

91.6

89.0

89.7

0.52

<0.01

<0.01

0.09

Fat Thickness, cm

1.65

1.63

1.63

1.63

1.60

0.038

0.81

0.66

0.97

USDA marbling 3

517

530

541

534

534

7.5

0.27

0.60

0.11

Calc. Yield
3.79
3.72
3.69
3.77
3.64
0.060
0.38
0.52
0.89
Grade4
1
Days on terminal implant (Revalor-200; Merck Animal Health) after initial implant (Revalor-IS; Merck Animal Health)
3
400 = small 00; 500 = modest 00; 600 = moderate 00
4
Calculated using the following equation: Yield grade calculated using the following equation: 2.5 + (0.98425 x 12th rib fat, cm) + (0.2 x 3.0
[KPH, %]) + (0.00837 x HCW, kg) – (0.0496 x LM area, cm2)
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Figure 3.2 Quadratic response and equations of variables across days on terminal implant for steers fed for 180 d (Exp. 2)
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Figure Description: Response to days on terminal implant in steers that were initially implanted with Revalor-IS (80 mg TBA + 16
mg estradiol; Merck Animal Health) and reimplanted with Revalor-200 (200 mg TBA + 20 mg estradiol) respective to treatment. A
quadratic response (P ≤ 0.03) was observed for carcass-adjusted final BW, ADG, G:F, and HCW. When solved for the first derivative,
DOT was maximized at 104, 99, 87, and 104, respectively.
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Table 3.9 Quadratic equations for response variables when steers are fed for 180 d (Exp. 2)

Response Variable

Equation

R2Value

Quad PValue

Carcass-Adj. BW

y = -0.00401x2 (±0.001125) +0.8352 (±0.2596) + 701.80 (±11.7339)

0.0248

0.03

Carcass-Adj. ADG

y = -0.0001906x2 (±0.0009277) – 0.0037804 (±0.001894) + 1.7087 (±0.0880358)

0.1027

0.02

Carcass Adj. G:F

y = 0.00000128x2 (±0.000000577) – 0.00022x (±0.0001179) +0.1587 (±0.005479)

0.1581

<0.01

HCW

y = -0.00252x2 (±0.0.002664) – 0.5251x (±0.5438) + 405.70 (±11.4725)

0.0247

0.03
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